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Abstract 
 
The Relationship between Health Literacy, Patient Activation, and 
Health Outcomes in Breast Cancer Patients 
 
Chisom Nnenna Kanu, PhD 
The University of Texas at Austin, 2019 
 
Supervisor:  Carolyn M. Brown 
 
The aim of this study was to evaluate the level of health literacy and patient 
activation in a sample of breast cancer patients as well as examine the relationships of these 
constructs to health outcomes. 
A cross-sectional study design was employed. HER-2 positive breast cancer 
patients receiving care at 12 oncology clinics in Texas who had scheduled office 
appointments between August and October 2018 were approached to participate in the 
study via convenience sampling. Patients who expressed willingness to participate in the 
study were given a 67-item survey to complete during their office visit. The survey 
consisted of the 6-item cancer health literacy measure (CHLT-6), the 6-item newest vital 
sign (NVS), the 13-item patient activation measure (PAM 13), the 27-item functional 
assessment of cancer therapy (FACT-G v. 4), two items measuring the quality of patient-
provider communication, and single item measures for the number of ED 
visits/hospitalizations as well as clinical and demographic patient characteristics. All 
variables were analyzed descriptively (means, frequencies). Bivariate and multivariate 
analyses were also conducted to assess the relationships between variables and predict 
health outcomes.  
 vii 
Almost 90 percent (N=146) of the 164 patients approached participated in the study. 
Results from the 146 study participants showed that the average age was 57.1±10.8 years. 
The majority were female (99%), Caucasian (72%), married or in a relationship (70%), at 
least had a college degree (53%), and had an annual household income over $50,000 (66%). 
Clinically, there was an almost equal distribution of patients from cancer stage 1 to stage 
4 and most patients had been diagnosed for the first time within the last 5 years (78%). 
Ninety-two percent (N=134) of participants had adequate cancer health literacy while 79 
percent (N= 114) had adequate general health literacy based on their CHLT-6 and NVS 
scores, respectively. The mean patient activation score was 65.9±15.7 (of a possible 100) 
with most patients (68%, N= 99) in the higher levels (level 3 or 4) of activation. The 
average quality of life based on an overall FACT-G score of 108 was high (82.6±16.1). 
Bivariate analysis showed significant positive relationships between cancer health literacy 
and educational level, and household income. Ethnic minorities were also found to have 
significantly lower patient activation scores compared to Whites. Multivariate analysis 
revealed that cancer health literacy, patient activation, educational level, and number of 
treatment types received explained 23 percent of the variation in quality of life, and all 
except cancer health literacy were positive and significant predictors. 
It is important to pay attention to modifiable factors such as patient activation that 
impact breast cancer patients’ quality of life in interventions aimed to improve quality of 
life, especially in ethnic minorities who tend to have lower patient activation levels. The 
high levels and homogeneity of cancer health literacy among study participants could have 
influenced its non-significant relationship with quality of life. Further assessments of 
health literacy and patient activation with quality of life as well as other health outcomes 
in larger and more diverse populations of breast cancer patients are warranted. 
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Chapter 1: Introduction 
This chapter gives a brief overview of breast cancer, its economic impact, the 
current treatment therapies, and the disease outcomes. It also introduces the concept of 
health literacy and patient activation. Patient activation aims to make patients with chronic 
diseases partners in their disease management while health literacy embodies the cognitive 
and social skills that determine the motivation and ability of individuals to use health 
information.  Finally, the study significance discusses the gap that this study aims to fill by 
assessing the relationship between patient activation, health literacy, and health outcomes 
in breast cancer patients. 
 
1.1 Breast Cancer 
Breast cancer refers to a group of diseases that affect breast tissue typically resulting 
from an uncontrolled growth of breast cells. Five to ten percent of breast cancers are due 
to inherited genetic abnormalities while 85 to 90 percent are due to genetic abnormalities 
resulting from the aging process and lifestyle.1 The symptoms of breast cancer are 
generally non-specific. However, the most common symptom is a new lump in the breast 
or underarm.  The classification of breast cancer depends on which breast cell becomes 
cancerous. Breast cancer can begin in the breast lobules, ducts, or connective tissue. The 
lobules produce milk, the ducts carry milk from the lobules to the nipple, and the 
connective tissue provides the breast framework. The majority of breast cancers begin in 
the ducts or lobules and less commonly in the stromal tissues, which include the fatty and 
fibrous connective tissues of the breast. The two main manifestations of breast cancer are 
invasive ductal carcinoma and invasive lobular carcinoma. Other less common kinds of 
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breast cancer include Paget’s disease, medullary, mucinous, and inflammatory breast 
cancer.2  
Cancerous breast cells can usually spread over time, invading nearby healthy breast 
tissue and making their way into the underarm lymph nodes, from where they travel to 
other parts of the body. Breast cancer staging refers to how far the cancer cells have spread 
beyond the original tumor site. The spread of cancer at the time of diagnosis determines 
the staging. Appropriate staging is necessary to determine treatment options and assess 
disease outcome. Clinicians generally prefer the TNM staging system which assesses 
cancers based on the tumor size (T), whether it has grown to involve nearby areas, absence 
or presence of regional lymph node involvement (N), and absence or presence of distant 
metastases (M). A tumor is assigned to a stage of 0, I, II, III, or IV after the T, N, and M 
categories are determined. Stage 0 refers to a noninvasive cancer which is limited to the 
cells of origin while stage IV is the most advanced, fully metastasized stage.3 
 
Breast Cancer Epidemiology 
Men and women can get breast cancer, but it is much more common in women. In 
United States women, breast cancer is the second most common cancer. Advanced age, 
genetic mutations, sedentary lifestyle, and the use of certain oral contraceptives are some 
factors that influence the occurrence of breast cancer. The risk of breast cancer increases 
with age, with an average age at breast cancer diagnosis of 61 years among women. About 
19 percent of breast cancers occur among women younger than 50 years, and 44 percent 
occur in women older than 65 years.2,3 In the United States, about 220,000 cases of breast 
cancer are diagnosed in women and about 2,000 in men, annually. Approximately 40,000 
women and 400 men die every year from breast cancer in the United States. It is the leading 
cause of cancer death among Hispanic women and the second leading cause of cancer death 
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among women in general. However, breast cancer deaths have declined over time. Over 
the last decade, the risk of getting breast cancer has not changed for women overall, but 
the risk has increased for black, Asian, and Pacific Islander women. Black women 
generally have a higher risk of death from breast cancer than white women.2  
 
Breast Cancer Management 
Advances in medicine have changed the prognosis for previously terminal diseases 
like cancer. In the United States, an appreciable percentage of individuals (41%) diagnosed 
with breast cancer have survived for a number of years after diagnosis.4 Improvements in 
treatment and earlier detection have increased the 5-year relative survival rates for female 
breast cancer patients in the past three decades with 5-year, 10-year, and 15-year breast 
cancer relative survival rates of 89 percent, 83 percent, and 78 percent, respectively.3,5  
The treatment choice for breast cancer depends on the breast cancer type and degree 
of spread. Surgery, chemotherapy, hormonal therapy, biological therapy, and radiation 
therapy can be employed to treat breast cancer independently or in combination.3 Breast 
cancer treatment usually involves breast-conserving surgery (lumpectomy/partial 
mastectomy), which involves removal of only cancerous tissue accompanied with radiation 
or non breast-conserving surgery (mastectomy) which involves surgical removal of the 
entire breast. With successful breast conserving surgery, long-term survival is the same as 
in treatment with mastectomy.6,7 Women under 40 years of age and patients with larger 
and/or more aggressive tumors are more likely to undergo mastectomy.8 In addition, 
patients eligible for breast-conserving surgery might opt for a mastectomy for reasons such 
as fear of recurrence or a reluctance to undergo radiation therapy.9,10 Following this 
description of breast cancer, its epidemiology, and disease management, is an explanation 
of the health literacy construct which is the primary independent variable in this study.  
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1.2 Health Literacy 
Health literacy refers to an individual’s ability to obtain, communicate, process, and 
understand basic health information and services in order to make appropriate health 
decisions.11,12 It is a complex phenomenon which involves individuals, families, 
communities, and systems. Health literacy incorporates a range of abilities including 
reading, analyzing information, decoding instructions, weighing risks and benefits, and 
making healthcare decisions.13 Individuals are increasingly being held accountable for 
making healthy lifestyle choices and managing their health in complex health care systems 
but are ill-prepared to take on these roles.14 Health literacy may be worse than an 
individual’s general literacy.15 In the United States, up to 90 million adults have low health 
literacy which translates into difficulty with understanding and using health information. 
Risky behaviour, poorer health, less self-management and more hospitalization result from 
weak health literacy competencies.13 These negative outcomes place a significant strain on 
human and financial resources in the health system.13 
 
Health Literacy Measurement 
Current instruments for measuring health literacy skill levels mainly capture an 
individual’s ability to read. There is no gold-standard instrument to adequately assess the 
global health literacy concept by capturing the interactions of reading ability, numeracy, 
and oral literacy. The most commonly used instruments to measure general health literacy 
are the Rapid Estimate of Adult Literacy in Medicine (REALM) and the Test of Functional 
Health Literacy in Adults (TOFHLA).16 Other instruments like the Newest Vital Sign 
(NVS) are also used to assess general health literacy in clinical practice.17 However, in 
2014, Dumenci et al. developed a cancer-specific health literacy instrument which 
measures cancer health literacy as a binary construct. Individuals are classified as either 
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having limited cancer health literacy or adequate cancer health literacy based on their 
responses to the six items in the instrument. There is evidence that supports the 
instrument’s reliability and validity. It has also been shown to have a high degree of 
specificity and sensitivity. Compared to individuals with adequate cancer health literacy, 
individuals with limited cancer health literacy are likely to be Black, under-educated, have 
low income, not be privately insured, and tend not to engage in health decisions.18 
 
Health Literacy and Cancer Care 
Cancer care in the United States is sub-optimal and the effects of the poorly 
coordinated, and fragmented system result in difficulties with coordinating care, accessing 
care, and obtaining relevant health information by oncology patients.19 Patients with low 
health literacy are particularly affected by this complex healthcare system with a limited 
capacity to obtain, process, and understand both written and verbal cancer information as 
well as access and navigate the system. This complex of factors significantly contribute to 
the high cancer mortality rates in the United States.12,20  
Health literacy is an important element in effective cancer communication, and it 
is often overlooked.21 Functional literacy is context-specific and in the case of cancer, it is 
likely that a significant number of individuals, regardless of literacy levels, lack a clear 
understanding of cancer control guidelines and screening recommendations. People that 
have been screened for cancer may lack basic understanding of test results and even cancer 
patients may lack adequate knowledge of treatment recommendations and clinical trial 
options.13  
An explanation of the patient activation construct, which is the secondary 
independent variable in this study, and is thought to mediate the effect of health literacy on 
health outcomes, follows. 
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1.3 Patient Activation  
Patient engagement is a broad concept that includes patient activation, the 
interventions designed to improve patient activation, and patients’ behavior as result of 
such interventions. Patient activation itself, refers to a patient’s understanding of his/her 
role in the healthcare process and the possession of knowledge, confidence, and skills to 
facilitate active participation in managing their health. This motivates a patient to become 
engaged by taking preventive actions, collaborating with providers, managing symptoms 
and problems, and finding and using high-quality and appropriate care.22-24  
 
Patient Activation Measurement  
Patient activation is a latent construct which can be measured using the patient 
activation measure (PAM). The PAM is a series of questions that estimate an individual's 
self-concept as a manager of his or her health and health care with response options that 
are degrees of agreement or disagreement. It was developed by Hibbard et al. in the early 
2000s and is a unidimensional and probabilistic, Guttman-like scale with evidence of 
validity and reliability. The PAM enables the assessment of an individual’s knowledge, 
skills, beliefs and confidence for managing health and healthcare.24,25  Activated patients 
understand that, apart from the care and support of medical practitioners, the sustenance of 
good health depends on their knowledge of their disease condition, the possession of skills 
to manage their symptoms and the confidence to take appropriate action when necessary.   
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Impact of Patient Activation on Health Outcomes  
Patient activation is a measurable  intermediate outcome of care that is linked with 
health outcomes.22 Studies have shown that patients with chronic conditions including 
diabetes and heart failure who have high activation levels place a lower burden on the 
health system and have better health outcomes.25-28  
Patients with low activation are twice as likely to delay medical care, and three 
times as likely to have unmet medical needs compared to patients with high activation.29 
In addition, highly activated patients get more out of available healthcare services due to 
their greater involvement in disease management. They are at least two times as likely to 
prepare questions for a physician visit, to know about treatment options for their disease, 
to seek health information, and to compare the quality of health care received from 
providers than patients with low activation.30,31 Consequently these highly activated 
patients are less likely to be hospitalized or visit the emergency department.25,32 
Patient activation is a modifiable factor and interventions tailored to individual 
patients’ activation levels have been shown to be effective in increasing patient activation. 
However, patients with the lowest activation tend to have greater improvements in 
activation when interventions are introduced compared to patients who already have high 
activation levels due to a ceiling effect.22,32-34 It is important to tailor interventions to a 
patient’s activation level by encouraging realistic behavior modifications. Such strategies 
have a greater chance of successfully increasing patients’ activation levels because 
challenging behaviors are less likely to be adopted by patients with low activation.23  
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Racial/Ethnic Variations in Patient Activation 
Compared to Caucasians and African Americans, Hispanics have much lower 
levels of patient activation with only 24.8 percent of Hispanics at the highest level of patient 
activation (activation level 4), compared to 39.5 percent of blacks and 45.3 percent of 
whites. Low acculturation and ability to navigate the American healthcare system have 
been identified as contributory factors to these differences which persist even after 
controlling for other demographic and socioeconomic factors. In addition, Hispanic breast 
cancer patients have the greatest odds for decision dissatisfaction and are more vulnerable 
to poor breast cancer treatment decision outcomes than patients of other ethnicities. 
Consequently, increased patient activation among this patient population might 
significantly reduce disparities in their access to and use healthcare.35,36 
 
Patient Activation and Health Promoting Behaviors 
Irrespective of disease type and economic level, highly activated patients have 
greater adherence to treatment regimens and are more likely to regularly perform self-
monitoring as well as obtain regular chronic care.25,31,37-39 A number of studies have 
examined the impact of activating patients with different chronic diseases such as diabetes, 
depression, HIV and hypertension and the results of these studies show the financial, 
clinical, and psychological benefits of such interventions.40-42 In addition, a recent study 
by O’Malley et al. specifically investigated the determinants of patient activation in a 
predominantly Caucasian (77%) and African American (15%) cohort of breast and prostate 
cancer survivors. The study results revealed that among the 213 breast cancer survivors, 
overall patient activation was high with a mean of 3.34±0.37 and this was significantly 
higher than that of the 112 prostate cancer survivors (3.25±0.38). Race, marital status, 
employment status, household income, and fear of recurrence were significantly associated 
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with patient activation for only prostate cancer survivors. Non-Caucasian, unmarried, 
unemployed, and low-income prostate cancer survivors had lower activation scores than 
Caucasian, married, employed, and high earning survivors, respectively. However, for both 
breast and prostate cancer survivors, ease of access to and perceptions of time spent with 
healthcare providers (oncology team and primary care physicians) were positive predictors 
of activation.43  
 
1.4 Study Significance  
Patient activation and health literacy are independent predictors of health and 
deficits in either of them could serve as targets for behavioral intervention.44,45 Higher 
activation helps individuals with low literacy and numeracy abilities to compensate for 
their lower skills and to achieve higher levels of comprehension. When health trade-offs 
are necessary, making the right choice depends on literacy and comprehension as well as 
patient activation.46 
A study by Hibbard et al. investigating the relationship between patient activation 
and health literacy showed that among older adults, both health literacy and patient 
activation were significantly and positively related to healthcare decision making, even 
though this relationship was stronger for health literacy.47 Patient activation had slightly 
stronger relationships to health-care-related behaviors, healthy behaviors, and self-
management behaviors than health literacy.47 Another study by Nijman et al. which 
examined the relative contribution of patient activation and functional health literacy to the 
seeking and use of health information showed that more activated consumers were more 
likely to seek and use health information. In the study population, health literacy increased 
as patient activation increased, with a weak to moderate overall correlation between the 
health literacy and activation scores.48  
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Recent studies in oncology reveal that health literacy and certain aspects of patient 
activation are associated. A cross-sectional, multicenter oncology study that examined 
patient activation, health literacy, symptom burden, confidence to self-manage side effects, 
and medication adherence to oral oncolytics showed that confidence to self-manage side 
effects (e.g., fatigue and diarrhea) were associated with higher health literacy and higher 
patient activation.49 Another study revealed that higher patient activation increases 
colorectal cancer screening in low income, minority patients with limited health literacy 
skills.50 
However, these studies were conducted in homogenous patient populations (95% 
Caucasian), were not specific to breast cancer patients, or did not illustrate the relationships 
of patient activation and health literacy to health outcomes and resource utilization. 
Measuring patient activation and health literacy will facilitate the provision of activation 
stage-appropriate information to breast cancer patients at their literacy level and thereby 
can increase the effectiveness of interventions geared toward improving patient 
involvement in managing their health. 
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Chapter 2: Literature Review 
This chapter contains the literature review of the major concepts in this project. The 
first section gives a detailed description of breast cancer, including its epidemiology, 
pathogenesis, diagnosis, treatment options, and economic burden. The second section 
discusses health literacy in the oncology space with emphasis on breast cancer patients. 
The third section reviews patient activation in chronic disease management with particular 
emphasis on its relevance in breast cancer patients. The final two sections explain the 
theoretical framework that this study is based on as well as the study significance. 
 
2.1 Breast Cancer 
Breast cancer refers to a group of diseases caused by the formation of malignant 
cells in breast tissues. These malignant cells are characterized by uncontrolled division 
resulting in abnormal growth. If left untreated, malignant breast cells can invade 
surrounding tissue, spreading to other parts of the body through blood and lymph vessels 
and leading to metastasis.2,51 
 
2.1.1 Breast Cancer Epidemiology 
Breast cancer is the most common cancer in women globally with about 1.7 million 
new cases diagnosed in 2012.52  There are generally higher rates of breast cancer in 
developed countries compared to developing countries. These differences might be due to 
lifestyle and reproductive patterns prevalent in developed countries. In addition, poor 
screening rates and incomplete reporting practices in developing countries play a role in 
fostering this disparity. Even though breast cancer is presumed to be a disease of the 
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developed world, about 69 percent of all breast cancer deaths occur in developing 
countries.52-54 
Breast cancer incidence rates vary greatly worldwide, with North America having 
the highest rate of up to 99.4 per 100,000. Eastern Europe, South America, Southern Africa, 
and Western Asia have moderate incidence rates, while African countries have the lowest 
incidence rates. The incidence rates are steadily increasing in moderate and low incidence 
areas. The pattern of cancer incidence in developing countries is expected to increasingly 
mirror that of developed countries with increasing westernization.52,55  
Although breast cancer occurs in males and females, it is much more common in 
women. In the United States, the American Cancer Society estimated 252,710 and 2,470 
new cases of invasive female and male breast cancer in 2017, respectively. In addition, 
41,070 female and 460 male breast cancer deaths were estimated in 2017.56 Breast cancer 
is the second most common cancer representing 14 percent of all new cancer cases in the 
United States and is the second leading cause of cancer death among women in general. 
The average American woman has a 12 percent risk of developing breast cancer in her 
lifetime.55,57  
Breast cancer incidence and death rates differ by ethnicity and geography in the 
United States. Generally, non-Hispanic White and Black women have higher rates than 
women of other racial or ethnic groups. Asian and Pacific Islander (API) women have the 
lowest incidence and death rates. Furthermore, White women have appreciably higher 
breast cancer incident rates than Black women between the ages of 60 and 84, while Black 
women have higher incidence rates before age 45 and are more likely to die from breast 
cancer at every age.55 A combination of factors are responsible for the higher mortality 
rates in Black women including later stage at diagnosis, obesity, comorbidities, and tumor 
characteristics. Poor access, adherence, and response to treatment as well as sub-optimal 
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mammography screening also contribute to this disparity.58-61 In 2012, breast cancer death 
rates were 42 percent higher in Black than White women.55 
In general, breast cancer deaths have declined over time and the risk of getting 
breast cancer has remained constant for women overall. However, over the last decade, the 
risk of getting breast cancer has increased for Black, and API women.2 Generally, breast 
cancer death rates per 100,000 women are higher for Black women than non-Hispanic 
White women. Breast cancer death rates range from 18.7 to 25.4 for White women, 21.7 
to 35.0 for Black women, 7.8 to 18.3 for Hispanic women, and 7.5 to 16.9 for API women. 
Breast cancer mortality rates among White women tend to be highest in the North Central, 
Mid-Atlantic, and Western regions of the United States, while the highest death rates for 
Black women are in California and some of the South Central and Mid-Atlantic states.55 
 
2.1.2 Economic Burden of Breast Cancer  
Breast cancer is expensive to treat from both personal and social perspectives. It is 
responsible for the largest share of cancer-related spending in the United States, 
constituting 13 percent of all cancer-related spending in 2010. In general, breast cancer 
diagnosed at an early stage is less expensive to treat than advanced stage breast cancer with 
an average treatment cost of $71,909, $97,066, $159,442, and $182,655 for stages 0, I/II, 
III, and IV, respectively in the first 24 months after diagnosis. In the United States, direct 
breast cancer medical expenses were $16.5 billion in 2010 and these costs are expected to 
increase to $20.5 billion by 2020.62,63 Indirect breast cancer medical costs are also 
significant and mainly result from lost wages, cancer-related death, and out-of-pocket 
payments for health services including hospitalization and physician visit copayments. 
Out-of-pocket expenditures and lost income average $1,455 per month and vary widely 
depending on insurance.64 Total annual indirect productivity costs for female breast cancer 
 14 
patients range from $344 million (18 to 44 years) to $1,511 million (45 to 64 years) due to 
a higher prevalence of breast cancer in the older population (0.3% vs 3%).65 On average, 
the financial burden of breast cancer accounts for 98 percent, 41 percent, and 26 percent of 
monthly income among female breast cancer patients with annual household income levels 
of <$30,000, $30,001-$60,000, and >$60,000, respectively.64 
Approximately 23 percent of breast cancer expenditures are made during evaluation 
and management in the year after diagnosis, while 41 percent and 36 percent are spent on 
continuing care and in the last year of life, respectively. Breast cancer patients usually 
survive for long periods of time and this explains why the continuing care phase accounts 
for the largest share of lifetime costs. Breast cancer has the highest continuing care and 
end-of-life expenditures in comparison to other malignancies.66 The distribution of costs 
in the year after diagnosis by type of therapy is about 25 percent, 15 percent, 11 percent, 
18 percent and 31 percent for surgery, chemotherapy, radiation therapy, other 
hospitalizations, and other services, respectively.67 
Even though total costs have been shown to be greatest during the continuing phase 
of breast cancer care, the cost per unit of time are greatest during the initial and terminal 
phases of care. The average annual net costs for women less than 65 years is $27,700, 
$2,200, and $94,300 per year during the initial, continuing phase, and last year of life, 
respectively. However, costs are usually lower for women 65 years and older, especially 
during the last year of life ($62,900 per year).62  
The out-of-pocket costs for breast cancer patients and their caregivers are 
approximately $2,700 to $7,900, respectively.68 For patients who were employed before 
their diagnosis of breast cancer, lost wages from time spent on treatment and disability 
have been estimated at $4,300 and $5,900, respectively.64,69-71 Total lost-productivity costs 
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from breast cancer deaths were estimated to be $10.9 billion in 2010, accounting for eight 
percent of all cancer-related productivity losses nationally.72 
 
2.1.3 Breast Cancer Risk Factors 
The exact cause of breast cancer is unknown. However, engaging in regular 
physical activity, maintaining a healthy body weight, and breastfeeding for at least one year 
have been associated with a reduced risk of breast cancer. On the other hand, several 
factors, both modifiable and non-modifiable, increase the risk of breast cancer occurrence. 
Potentially modifiable risk factors include excessive weight gain, physical inactivity, 
postmenopausal hormone use, alcohol consumption, long term smoking, and consistent 
sleep pattern disruption.56 Advanced age is a significant non-modifiable breast cancer risk 
factor, with an average age at breast cancer diagnosis of 61 years in women. About 19 
percent of breast cancers occur among women younger than 50 years, and 44 percent occur 
in women older than 65 years.2,3 Personal or family history of breast cancer also 
significantly affects the occurrence of breast cancer. Individuals with a family history of 
breast cancer, especially in a first-degree relative, have a higher risk of developing breast 
cancer. This risk multiplies as the number of affected first-degree relatives increases.73 
Inherited cases of breast cancer are usually associated with two abnormal genes: BRCA1 
(BReast CAncer gene 1) or BRCA2 (BReast CAncer gene 2). Abnormal BRCA1 or BRCA2 
genes are found in five to 10 percent of all breast cancer cases in the United States. Women 
who inherit a mutation in either of these genes have about a 60 percent risk of being 
diagnosed with breast cancer during their lifetimes which is much higher than the 12 to 13 
percent risk for women overall.74,75 
Other non-modifiable risk factors include high breast tissue density, high-dose 
radiation to the chest at a young age, and type 2 diabetes. In addition, recent use of oral 
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contraceptives, never having children, having one’s first child after age 30, long menstrual 
history, and high level of sex hormones are reproductive factors that increase breast cancer 
risk.56 
 
2.1.4 Breast Cancer Signs and Symptoms 
The symptoms of breast cancer are generally non-specific. There are usually no 
symptoms when the breast tumor is small and has the best likelihood of positive treatment 
response. However, the most common sign is a new lump in the breast or underarm. Breast 
cancer can spread to underarm lymph nodes causing a lump or swelling before the breast 
tumor itself can be felt. Besides cancer, many other conditions can cause breast lumps 
including breast fibrosis and simple cysts, adenosis, fibroadenomas, and phyllodes tumors. 
In general, persistent changes in the breast should be evaluated by a physician as soon as 
possible. Pain is not a good indicator of breast cancer occurrence. In addition to breast 
lumps, other signs of breast cancer include:2,55 
 Thickening or swelling of part of the breast. 
 Irritation or dimpling of breast skin. 
 Redness or flaky skin in the nipple area or the breast. 
 Pulling in of the nipple or pain in the nipple area. 
 Nipple discharge other than breast milk, including blood. 
 Any change in the size or the shape of the breast. 
 Pain in any area of the breast. 
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2.1.5 Detection of Breast Cancer 
Breast cancer screening involves checking for breast cancer prior to the 
manifestation of any signs or symptoms. Breast cancer screening does not prevent breast 
cancer. However, early detection is associated with a greater number of treatment options 
and an increased likelihood of treatment success.76 The two main tests used for breast 
cancer screening are mammograms which produce an X-ray of the breast, and breast 
magnetic resonance imaging (MRI) which uses magnets and radio waves to produce an 
image of the breast. Breast MRIs are used along with mammograms to screen women who 
have a high risk for getting breast cancer. They are not used for women at average risk 
because MRIs may appear abnormal even when there is no cancer. Breast ultrasound and 
biopsies are additional techniques that are used to diagnose breast cancer. The United 
States Preventive Services Task Force (USPSTF) recommends that 50 to 74-year-old 
women with an average risk for breast cancer should get a mammogram biannually.  
Current evidence is insufficient to assess the balance of benefits and harms of screening 
mammography in women aged 75 years or older. Women younger than 50 years are 
advised to weigh the benefits and risks of screening tests with the guidance of their 
healthcare provider when making decisions about when and how often to get 
mammograms.2,77 
 
2.1.6 Breast Cancer Classification 
Even though breast cancer is generally considered to be a single disease, it is 
actually distinguished by different subtypes which vary in biological presentation, 
treatment response, and outcomes. In addition, these subtypes are associated with distinct 
risk factors. Breast cancer can be classified based on histopathology, molecular 
characteristics, and cancer stage.55 Details of these subtypes are described below. 
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A. Classification Based on Histopathology 
The classification of breast cancer based on cancer type depends on which breast 
cell(s) becomes cancerous. Breast cancer can begin in the breast lobules, ducts, or 
connective tissue. The lobules produce milk, the ducts carry milk from the lobules to the 
nipple, and the connective tissue provides the breast framework. The majority of breast 
cancers begin in the ducts or lobules and these cancerous cells could either be confined to 
the cells where they originate (in situ) or spread to other areas of the body (invasive). The 
few cancers that start in other breast tissues are considered to be sarcomas and lymphomas. 
Other less common kinds of breast cancer include Paget’s disease, medullary, mucinous, 
and inflammatory breast cancer.2,55,57 Details of the different breast cancer types are 
discussed below. 
 
1. Breast Cancer in situ 
Intraductal carcinoma 
This type of breast cancer is also referred to as ductal carcinoma in situ (DCIS) and 
makes up about 20 percent of new breast cancer cases. It occurs when the normal epithelial 
cells of the breast ducts are replaced by abnormal cells, leading to considerable expansion 
of the ducts and lobules. The abnormal cells in this noninvasive form of breast cancer do 
not grow beyond the cells of origin. DCIS may or may not progress to invasive cancer over 
time but, because it is impossible to predict the disease progression, almost all women with 
a diagnosis of DCIS receive treatment.55,57 
Between 2008 and 2012, 83 percent of newly diagnosed in situ female breast cancer 
cases were DCIS. There are about 60,000 DCIS cases diagnosed in the United States 
annually. Individuals who had a prior episode of DCIS have a higher risk for recurrence 
and development of a new breast cancer than those who have never had breast cancer. The 
 19 
chances of a recurrence are under 30 percent and recurrences usually occur within five to 
ten years of the initial diagnosis55,75 
 
Intralobular Carcinoma 
This type of breast change is also referred to as lobular carcinoma in situ (LCIS) or 
lobular neoplasia and consists of cancer-like cells growing within the breast lobules. Even 
though the name includes the term “carcinoma,” LCIS is not a true breast cancer. It is not 
generally considered to be a precursor of invasive cancer because it does not spread if left 
untreated. However, it is thought to indicate an increased risk of developing invasive 
cancer. LCIS does not typically have conspicuous symptoms and is typically discovered 
during a biopsy for another proximal breast problem. LCIS is extremely uncommon in men 
and is usually diagnosed between the ages of 40 and 50 in women, before menopause. It is 
less common than DCIS and accounted for about 13 percent of in situ breast cancers 
diagnosed in women between 2008 and 2012.55,57,75  
 
2. Invasive Breast Cancer 
Invasive Intraductal Cancer 
This type of breast cancer, also known as infiltrating ductal carcinomas (IDC), is 
the most common type of breast cancer, comprising up to 80 percent of all invasive breast 
cancers. It typically originates in the breast milk ducts then breaks through the ductal wall 
to grow into nearby tissues. From this point, it can spread (metastasize) to other parts of 
the body through the blood and lymph circulatory systems. IDC can affect women at any 
age. However, it is more common in older women and about two-thirds of women are 55 
or older when they are diagnosed.57,75 Rare subtypes of invasive ductal carcinoma include 
medullary, tubular, mucinous, papillary, and cribiform carcinomas of the breast.75 
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Invasive Lobular Carcinoma 
Invasive lobular carcinoma (ILC), also referred to as infiltrating lobular carcinoma, 
is the second most common type of breast cancer after invasive ductal carcinoma. ILC 
typically starts in the milk-producing glands (lobules) and like IDC, it can spread 
(metastasize) to other parts of the body. ILCs constitute about 10 percent of the 180,000 
invasive breast cancers diagnosed in the United States annually. Compared to IDC, ILC 
may be harder to detect on physical exam and imaging procedures such as mammograms. 
Consequently, a combination of tests is usually employed in diagnosing ILC. Furthermore, 
ILC tends to affect more than one area of the breast (multifocal) and in comparison to other 
types of invasive breast cancer, is more likely to affect both breasts (bilateral).57,75  
 
3. Other Breast Cancer Types 
Inflammatory Breast Cancer 
Inflammatory breast cancer (IBC) is a rare and aggressive form of breast cancer 
that constitutes about one percent of all breast cancer cases in the United States. IBC 
usually starts with a feeling of thickness or heaviness in the breast which results from 
cancer cells clogging the lymph vessels. IBC is characterized by breast reddening and 
swelling instead of a distinct lump like in other breast cancer manifestations. It typically 
spreads quickly, and symptoms can worsen within hours. IBC affects men as well as 
women. In the United States, IBC is more common in African American women and is 
typically diagnosed at an average age of 52 years in black women and 57 years in white 
women. IBC symptoms are similar to mastitis and cellulitis but unlike these bacterial 
infections, its symptoms are usually confined to the breast and it is not resolved by 
antibiotic treatment.75 
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Paget's Disease of The Nipple 
Paget's disease is also a rare form of breast cancer that constitutes less than five 
percent of all breast cancer cases in the United States. This cancer usually affects the ducts 
of the nipple first before spreading to the nipple surface and areola. Unusual changes in the 
nipple and areola are typically early signs of breast cancer. Most people with Paget's 
disease (> 97%) also have DCIS or invasive cancer somewhere else in the breast. Paget's 
disease of the nipple affects men and women but is more common in women and usually 
develops after the age of 50. The average age at diagnosis is 62 years in women and 69 
years in men.75 
 
Phyllodes Tumors of The Breast 
Also known as phylloides tumor and cystosarcoma phyllodes, these tumors account 
for less than one percent of all breast cancers. Benign, malignant, and borderline phyllodes 
grow quickly but are typically contained within the breast. Surgery is required to reduce 
the risk of local recurrence. Even though phyllodes tumors usually develop when a woman 
is in her 40s, they can occur at any age. Phyllodes tumors are extremely rare in men.75 
 
B. Classification Based on Molecular Characteristics 
The genes that a cancer expresses determine the molecular subtype. Routinely 
evaluated biological markers have been used to identify molecular subtypes of breast 
cancer. These markers include the presence or absence of hormone (estrogen or 
progesterone) receptors (HR+/HR-), excess levels of human epidermal growth factor 
receptor 2 (HER2+/HER2), and a growth-promoting protein (Ki-67) .55 The main 
molecular subtypes of breast cancer in order of increasing severity are luminal A breast 
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cancer, luminal B breast cancer, triple-negative breast cancer, and HER2-enriched breast 
cancer. These subtypes are described below: 
 
Luminal A Breast Cancer (HR+/HER2-)   
This type of breast cancer is estrogen-receptor and/or progesterone-receptor 
positive, HER2 negative, and has low levels of the protein (Ki-67) which controls the rate 
of cancer cell growth. Seventy four percent of breast cancers have these characteristics. In 
general, luminal A cancers are low-grade, tend to grow slowly, are less aggressive than 
other subtypes, and have the best short-term prognosis.78,79 
 
Luminal B Breast Cancer (HR+/HER2+) 
This type of breast cancer is similar to luminal A breast cancer being hormone-
receptor positive (estrogen-receptor and/or progesterone-receptor positive). However, it 
could be either HER2 positive or HER2 negative and has high levels of Ki-67. Luminal B 
cancers account for about 10 percent of breast cancers. They grow a bit faster than luminal 
A cancers and have a slightly poorer prognosis.80 
 
Triple-Negative Breast Cancer (HR-/HER2-) 
This type of breast cancer is hormone-receptor negative (estrogen-receptor and 
progesterone-receptor negative) and HER2 negative. About 12 percent of breast cancers 
are triple negative. This breast cancer subtype is more common in premenopausal women 
and those with a BRCA1 gene mutation. In addition, African American women are nearly 
two times more likely to have this cancer subtype compared to Caucasian women.81 Triple 
negative breast cancers have the poorest short-term prognosis compared with  other breast 
cancer subtypes, and this is due, in part, to the lack of targeted therapies for these tumors.79 
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HER2-Enriched Breast Cancer (HR-/HER2+) 
This type of breast cancer is hormone-receptor negative and HER2 positive. About 
4 percent of breast cancers produce excess HER2 and do not express hormone receptors. 
Even though HER2-enriched cancers grow faster than other breast cancers and have a 
poorer short-term prognosis, they can be successfully treated with targeted therapies aimed 
at the HER2 protein.55,79 
 
C. Classification Based on Stage  
The spread of cancer at the time of diagnosis and tumor characteristics determine 
staging. Appropriate staging is necessary to determine treatment options and assess disease 
outcome. The two common staging systems, the TNM system and the Summary stage 
system, are described in detail below.  
 
TNM Staging System 
This staging system was developed by the American Joint Committee on Cancer 
(AJCC) and the Union for International Cancer Control (UICC). It is commonly used by 
medical professionals to stage breast cancer as well as other cancer types. This staging 
system is based on the extent of the tumor (T), the extent of spread to the lymph nodes (N), 
and the presence of metastasis (M).82 
The T category describing the primary tumor is used to denote when the primary 
tumor cannot be evaluated (TX), when there’s no evidence of primary tumor (T0), when 
there is carcinoma in situ (Tis), and size/extent of the primary tumor (T1 – T4; higher 
numbers depict greater size).  The N category is used to describe when regional lymph 
nodes cannot be evaluated (NX), when no cancer is found in the lymph nodes (N0), and 
when there is regional lymph node involvement (N1 – N3; higher numbers depict greater 
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involvement). Lastly, the M category indicates whether or not there is distant metastases 
using M0 (no distant metastasis), and M1 (for distant metastasis).82 
Once the T, N, and M classifications are determined, they are combined to derive 
an overall cancer stage of 0, I, II, III, or IV. Stage 0 refers to a noninvasive cancer which 
is limited to the cells of origin while stage IV is the most advanced, fully metastasized 
stage. Lower stage cancers with minimal advancement typically have a better prognosis, 
while higher stage cancers are often more advanced but can still be treated successfully 
with recent advances in oncology medicine.82  
 
Summary Stage System 
Population-based cancer registries utilize the Surveillance, Epidemiology, and End 
Results Program (SEER) summary stage system which classifies cancers as in situ, local, 
regional, or distant by assigning one of nine single-digit codes to describe the tumor extent 
at the time of diagnosis. The codes for summary staging are in ascending order with higher 
numbers indicating more advanced tumor growth. The nine possible codes for summary 
stage are as follows:83 
0 = In-Situ  
1 = Local  
2 = Regional disease by direct extension only 
3 = Regional disease with only regional lymph nodes involved  
4 = Regional disease by both direct extension and regional lymph node(s)  
5 = Regional disease that is not otherwise specified  
7 = Distant sites or distant lymph node involvement  
8 = Benign and borderline CNS tumors  
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9 = Unknown if there is extension or metastatic disease (unstaged, death certificate 
only cases)  
The TNM and summary staging systems correspond to each other as follows:55  
 Stage 0 corresponds to in situ stage 
 Stage I corresponds to local stage 
 Stage II corresponds to either local or regional stage depending on lymph node 
involvement 
 Stage III corresponds to regional stage 
 Stage IV corresponds to distant stage 
 
2.1.7 Breast Cancer Treatment 
A multidisciplinary cancer care team consisting of medical, surgical and radiation 
specialists typically collaborate to plan and provide care to breast cancer patients.  The 
treatment choice for breast cancer depends on the breast cancer type and degree of spread. 
One or more of the following approaches can be employed to treat breast cancer: 
 Surgery which involves excision of cancer tissue. 
 Chemotherapy which involves the use of medications to shrink or kill the cancer 
cells.  
 Hormonal therapy which involves antagonism of the hormones that cancer cells 
need to grow. 
 Biological therapy which boosts the body’s immune system and enables it to fight 
cancer cells or to control side effects from other cancer treatments. 
 Radiation therapy which utilizes high-energy rays (similar to X-rays) to kill the 
cancer cells. 
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Breast cancer treatment usually consists of breast-conserving surgery 
(lumpectomy/partial mastectomy), which involves removal of only cancerous tissue 
accompanied with radiation or non breast-conserving (mastectomy) which involves 
surgical removal of the entire breast. With successful breast conserving surgery, long-term 
survival is the same as in treatment with mastectomy.6,7 Women under 40 years of age and 
patients with larger and/or more aggressive tumors are more likely to undergo 
mastectomy.8 In addition, patients eligible for breast-conserving surgery might opt for a 
mastectomy for reasons such as fear of recurrence or a reluctance to undergo radiation 
therapy.9,10 
About 61 percent of women with early stage (I or II) breast cancer opt for breast-
conserving surgery while 36 percent prefer to have a mastectomy. The reverse case occurs 
among women with stage III disease, 21 percent of whom undergo breast-conserving 
surgery while 72 percent opt for a mastectomy. Of women with stage IV breast cancer, 48 
percent receive radiation and/or chemotherapy without surgery, 25 percent receive surgery 
alone or in combination with other treatments, and 28 percent of patients receive no 
treatment.3  
Post-surgery, breast reconstruction with either a saline or silicone implant or tissue-
based reconstruction (such as flaps) are available for women who undergo mastectomy. Up 
to 57 percent of women with early stage I or II breast cancer who receive mastectomies 
undergo reconstructive procedures.3,10,75 
Systemic therapy is also employed in the management of breast cancer. The choice of 
chemotherapy, hormonal therapy, or targeted therapy depends on factors like tumor size, 
number of lymph nodes involved, presence of estrogen or progesterone hormone receptors 
on cancer cells, and amount of HER2 protein made by the cancer cells.3 About 84 percent 
of all female breast cancers test positive for hormone receptors84 which make these cancers 
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eligible for treatment with hormonal therapy.3 Table 2.1 contains a summary of treatment 
recommendations according to breast cancer sub-type.85 
 
Table 2.1: Systemic Treatment Recommendations According to Molecular Sub-Type 
for Non-Metastatic Disease 
Subtype Type of therapy 
Luminal A Endocrine therapy alone according to menopausal status. Chemotherapy also used in some cases. 
Luminal B 
Endocrine therapy appropriate according to 
menopausal status plus adjuvant chemotherapy in 
some cases 
Hormone receptor positive and 
HER2 positive 
Chemotherapy plus trastuzumab plus endocrine 
therapy appropriate for menopausal status 
Hormone receptor negative and 
HER2 positive Chemotherapy plus trastuzumab 
Triple negative Chemotherapy (anthracyclines and taxanes most 
commonly used) 
 
When necessary, hormonal therapy is started upon completion of chemotherapy 
and radiation. The main drugs employed are tamoxifen and aromatase inhibitors and the 
choice of hormonal therapy usually depends on a woman’s menopausal stage. Tamoxifen 
is the standard hormonal treatment for premenopausal women and is used for a minimum 
of 5 years, while tamoxifen and/or an aromatase inhibitor are used in post-menopausal 
women for 5 to 10 years.86 Targeted therapies are available for optimal treatment of breast 
cancers that have certain markers like HER2 which is expressed in about 14 percent of 
breast cancers. Targeted therapies can be given as single agents or in combination with 
chemotherapy or hormonal therapy.3,84 
Despite the efficacy of current breast cancer treatment regimens, breast cancer 
patients are usually burdened with the unpleasant side effects of treatment.75 An 
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individual’s health literacy and ability to self-manage health (patient activation) are 
important factors that influence whether a patient knows if and when to seek care for 
symptoms instead of unnecessarily enduring a poor quality of life -before worsening 
symptoms become severe enough to warrant a visit to the emergency department or 
hospitalization. These factors also influence a patient’s ability to coordinate their care. 
Furthermore, health literacy and patient activation might influence a breast cancer patient’s 
ability to detect new symptoms which could signal a disease recurrence.11,25,26,47 Early 
detection of breast cancer recurrence could facilitate treatment at an early disease stage 
which significantly increases the chances of treatment success and survival,75 highlighting 
the potential importance of health literacy and patient activation on health outcomes. 
 
2.2 Health Literacy 
Health literacy influences the extent to which a patient engages in self-care and 
chronic disease management. It is defined as the degree to which an individual can obtain, 
communicate, process, and understand basic health information and services needed to 
make appropriate health decisions.87  Health literacy involves a complex set of skills 
including reading, listening, speaking, writing, analytical, and decision-making skills 
which influence an individual’s ability to navigate health situations. Health literacy is 
considered an intermediate health outcome that is influenced by social and cultural factors 
at home, at work, and in the community as well as educational, communication, and health 
services factors.88,89  
Health consumers are increasingly encouraged to become involved in managing 
their health and healthcare with the paradigm shift towards patient-centered care. This 
requires individuals to assume new roles in seeking health-related information, 
understanding rights and responsibilities, and making health decisions for themselves and 
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others. However, the average patient does not have the necessary skills and knowledge 
needed to successfully perform these new patient roles.88 People of all ages, races, income, 
and education levels are affected by the scourge of limited health literacy, and even highly 
educated individuals often find typical health information and services to be unfamiliar, 
complicated, and technical.90  
The nationally representative health literacy survey (National Assessment of Adult 
Literacy) conducted by the U.S. Department of Education in 2003 included over 19,000 
adults aged 16 and above and classified health literacy into four levels; proficient, 
intermediate, basic, and below basic. The majority of adults (53%) had intermediate health 
literacy skills. However, 36 percent of survey respondents had the two lowest health 
literacy levels, implying that almost 80 million adults in the United States have limited 
health literacy. These adults would probably have difficulty with even simple tasks such as 
reading and understanding the instructions on a prescription bottle or filling out an 
insurance form.90 
The survey results also revealed that only 12 percent of English-speaking adults in 
the United States have proficient health literacy skills, with lower socioeconomic and 
minority groups having the highest rates of limited health literacy. The proportion of adults 
with below basic health literacy (the lowest level) was lowest for Whites (9%) compared 
to Blacks (24%), Asian (13%), Hispanic (41%), and American Indians/Alaska Natives 
(25%). This disparity might be due to the quality of education received by disadvantaged 
members of these ethnic minority groups as well as language and acculturation barriers.90 
In addition, almost half (49%) of adults with less than a high school degree had the 
lowest health literacy level and this percentage decreased significantly as education level 
increased, with only three percent of college graduates having below basic health literacy. 
Furthermore, age had a minimal relationship to health literacy among adults who were 
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under 65 years of age. However, adults who were 65 years or older were more likely to 
have below basic or basic health literacy skills compared to those under 65. Lastly, over 
50 percent of publicly insured and uninsured adults had low health literacy skills compared 
to less than 25 percent of privately insured adults.90 
Low health literacy is a major source of economic inefficiency in the American 
health care system. In 2007, Vernon et al. estimated the cost of low health literacy to range 
from $106 billion to $238 billion annually, which represents seven to seventeen percent of 
all personal health care expenditures.91 In addition, emergency room costs are significantly 
higher for individuals with inadequate health literacy compared to those with adequate 
health literacy.92 
Improving health communication reduces health care costs and increases the quality of 
health care. Both health care providers and patients play important roles in health literacy 
and clear communication is essential between these two parties. To achieve a more active 
role in health-related decisions, patients need to develop strong health information skills 
while healthcare providers need to utilize effective health communication skills. 
Furthermore, plain language should be employed in writing printed and web-based 
information.1 Such measures will make patients more successful in:  
 Finding needed health information and services; 
 Communicating their needs and preferences and responding to information and 
services; 
 Processing the meaning and usefulness of the information and services; 
 Understanding the choices, consequences and context of the information and 
services; and 
 Deciding which information and services match their needs and preferences so they 
can act. 93 
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2.2.1 Health Literacy and Health Outcomes 
Low health literacy can have a significant impact on an individual's health. 
Individuals with low health literacy have a decreased ability to share in decision-making 
pertaining to their care.94 Compared to adequate literacy, low or inadequate literacy has a 
much stronger correlation to poor knowledge and comprehension of health care services 
and health outcomes. Low health literacy has also been associated with increased chances 
of hospitalization, higher prevalence and severity for some chronic diseases, poorer global 
measures of health, and lower utilization of screening and preventive services.95 Health 
literacy has also been associated with preventable emergency department visits. Patients 
with limited literacy have 2.3 times the number of preventable ED visits resulting in 
hospital admission compared to individuals with adequate health literacy.96  
However, the bivariate associations between health literacy and health outcomes 
often become weak and statistically nonsignificant after adjustments are made for 
covariates such as age, education, socioeconomic status, health care access, or experience 
in the health care setting. This raises doubts about whether low health literacy is truly an 
independent problem or simply a marker of other social problems. Based on these findings, 
some of the recommendations of Dewalt et al. in their 2004 review article were that future 
research examining the relationship between health literacy and health outcomes should 
closely examine factors that could confound (e.g., age, income, and health insurance status) 
and mediate (e.g., self-efficacy, self-care, trust, and satisfaction) the relationship.95  
Interventions to increase health literacy and self-efficacy have shown 
improvements in hemoglobin A1c, glucose, and total cholesterol as well as medication 
adherence in diabetic and HIV patients.97-101  
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2.2.2 Health Literacy in Cancer Patients 
Health literacy is increasingly recognized as a critical factor affecting 
communication across the continuum of cancer care. Low health literacy has been 
associated with diminished cancer screening, advanced stage at diagnosis, and reduced 
quality of patient-physician interaction.13 
 
Cancer Screening and Health Literacy 
With regards to cancer screening, individuals with low literacy have a limited 
knowledge of anatomy and cancer-related medical terms. Consequently, they are less likely 
to comprehend the information contained in cancer control interventions or the medical 
terms commonly used in patient-physician communication.13,102  
Individuals' attitudes toward cancer screening and their sources of cancer 
information are affected by their health literacy level. A study by Davis et al. examined the 
relationship between reading ability and the knowledge and attitudes of low-income 
women regarding screening mammography in a convenience sample of over 400 women. 
Study results showed that compared to women with marginal and adequate literacy, 
patients with low literacy were significantly more likely to have negative attitudes toward 
mammograms, considering them to be embarrassing, harmful, painful, or bothersome to 
get. In addition, these women were more likely to be influenced by friends and relatives in 
their decision to get a mammogram.102 In general, limited health literacy has a varied effect 
on cancer screening compliance. Poor health literacy is associated with less knowledge and 
more misunderstanding about cancer susceptibility, detection, and prognosis which may 
influence cancer screening practices.13 
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Cancer Stage at Diagnosis and Health Literacy 
Health literacy has also been associated with cancer stage at diagnosis. Bennett et 
al.  conducted a study to evaluate the association between poor health literacy and higher 
rates of advanced prostate cancer stage at presentation among low-income men receiving 
care in equal-access medical systems. The study results showed that patients with low 
literacy skills were more likely to be diagnosed at a later prostate cancer stage. Specifically, 
men reading below a sixth-grade level were 69 percent more likely to be diagnosed with 
the most advanced stage (stage D) of prostate cancer than those reading above a sixth-grade 
level. Compared to white men, black men were almost twice as likely to present with stage 
D prostate cancer and were significantly more likely to have literacy levels less than sixth 
grade. However, race was not a significant predictor of advanced-stage prostate cancer at 
presentation after adjustment for differences in literacy, age, and city. They concluded that 
low literacy may be an overlooked but significant barrier to the diagnosis of early-stage 
prostate cancer among low-income white and black men.103 Whether or not health literacy 
is related to breast cancer stage in women is relatively unknown. 
 
Patient-Physician Communication  
Communication is an essential clinical skill in medical oncology practice, and 
health literacy plays a key role in cancer patients’ ability to discuss their disease with an 
oncologist in a meaningful way. Low health literacy influences both verbal and written 
communication between patients and their healthcare providers. There is often a mismatch 
between the way providers give out information and the way patients understand, 
remember, and apply the same information.21,104 Oncologists and other health-care 
providers typically use information based on facts, probability, and their previous clinical 
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experience when discussing cancer treatment and prognosis with patients. However, the 
ability of patients to understand this kind of information is usually overlooked.  
Furthermore, patients’ emotional state during discussions of cancer diagnosis and 
treatment may also interfere with their understanding and recall of the information 
provided.21 A study conducted by Davis et al. to analyze lifetime and 5-year breast cancer 
risk perceptions in 254 women aged 40 to 85 years showed that participants had a mean 
estimation error for lifetime and 5-year risk of 29.5 percent and 24.8 percent, respectively. 
These estimation errors were significantly correlated with lower numeracy rates.105 
Many words that physicians consider to be “everyday language” may not be clearly 
understood by the general population.106 Patients with low health literacy tend to be more 
responsive to information based on a health belief model where priority is given to patient 
action, motivation, and self-empowerment. Patients, especially those with low health 
literacy, are most interested in information that improves their sense of well-being and 
helps them resolve their immediate health problems.107  
 
2.2.3 Health Literacy Measurement 
Current instruments for measuring health literacy skill levels mainly capture an 
individual’s ability to read. There is no gold-standard instrument to adequately assess the 
global health literacy concept by capturing the interactions of reading ability, numeracy, 
and oral literacy. The most commonly used instruments to measure health literacy are the 
Rapid Estimate of Adult Literacy in Medicine (REALM) and the Test of Functional Health 
Literacy in Adults (TOFHLA).16 However, these instruments are lengthy and are not ideal 
for quickly identifying patients with limited health literacy in clinical practice. 
Consequently, other instruments like the Newest Vital Sign (NVS) have been designed for 
use in clinical practice.17 
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The REALM is a 66-item measure of health literacy which can be administered in 
1-2 minutes by minimally trained personnel. It is used to assess whether an individual can 
correctly pronounce a series of health-related words listed in order of increasing difficulty. 
The REALM scores individual’s health literacy on a continuous scale from 0-66. It has 
been validated as an instrument of reading ability and is highly correlated with traditional 
reading assessments.108 Other versions of the REALM include a 7-item short form 
(REALM-SF),109 an 8-item short form (REALM-R),110 and a version for teens (REALM-
Teen).111 
The TOFHLA employs a different approach to measure health literacy, assessing 
both reading skills and numeracy. It consists of 17 items that measure numerical ability 
and three prose passages measuring reading comprehension. This health literacy 
instrument is not self-administered and takes up to 22 minutes to complete. For the reading 
comprehension, individuals are required to read health-related passages and fill in the 
blanks from a selection of four choices for each omitted word. Numeracy skills are assessed 
by asking a subject to respond to health-related prompts, such as pill bottle instructions and 
appointment slips.112 The reading comprehension and numeracy subtests are highly 
correlated with each other (r = 0.79), and the TOFHLA as a whole is highly correlated with 
the REALM (r = 0.84).112 The TOFHLA also has a short version (S-TOFHLA) which 
consists of four items to measure numeracy and two prose passages.113 
The Newest Vital Sign (NVS) was developed by Weiss et al. in 2005 to assess the 
level of general health literacy in the primary care setting. The NVS uses an ice-cream 
nutrition label and six questions to assesses math, reading, and comprehension skills as 
well as abstract reasoning.  
The NVS has good sensitivity and might be more sensitive than the TOFHLA to 
marginal health literacy.17 In addition, its specificity is similar to or better than that of other 
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widely used clinical screening methods used to detect alcohol abuse,114 detect arthritis,115 
measure osteoporosis risk,116 and screen for breast cancer.117 Despite the instrument’s risk 
of overestimating the percentage of patients with limited literacy, it is a useful tool that can 
alert physicians to patients who may need more attention, and consequently help physicians 
pay more attention to improving physician-patient communication.17 
Even though these instruments have good psychometric properties and are widely 
used, they were developed to measure general health literacy. Cancer patients are a unique 
subset of patients and these instruments would most likely be inadequate to accurately 
capture a cancer patient’s ability to obtain, communicate, process, and understand cancer-
specific health information and services needed to make appropriate health decisions. This 
led to the development of cancer-specific health literacy instruments in recent times. 
 
Cancer Health Literacy Tool 
In 2014, Dumenci et al. published an article describing the development of two 
cancer-specific health literacy instruments. One was designed to measure cancer health 
literacy along a continuum and the other was designed to identify patients with limited 
cancer health literacy. The instrument development process involved a mixed method 
approach. The qualitative phase was used to identify the boundaries of cancer health 
literacy to ensure comprehensive content coverage. A Delphi panel was employed to gain 
the insight into the perspectives of 11 health literacy scholars and clinicians, while six focus 
groups were conducted for 39 cancer patients to elicit their understanding of cancer health 
literacy. Each focus group had a balanced mix of males and females, as well as different 
ethnic groups. The groups were also stratified by the highest level of educational 
qualification.18 
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The list of cancer health literacy items which resulted from the qualitative phase 
was used to generate 76 items which were administered to 1,306 head and neck (26.2%), 
breast (16.3 %), skin (11.7%), genitourinary (10.3%) and other (35.5%) cancer patients. 
The data generated from this quantitative phase were used to create the final instruments 
as well as provide validity and reliability evidence. Thirty items resulted after examining 
exploratory factor analysis results, percentage of correct item responses, item-corrected 
total correlations, gender and race/ethnicity differences in item responses, and content 
coverage analysis. These 30 items make up the cancer health literacy tool (CHLT-30) 
which measures cancer health literacy along a continuum. Upon further statistical analysis, 
the six most informative items which could be used to identify individuals with limited 
cancer health literacy were used to form the second instrument, the CHLT-6.18 The 
psychometric properties of these two instruments are discussed in more detail below. 
 
Cancer Health Literacy Tool 30-item (CHLT-30) 
The CHLT-30 instrument supports the unidimensional representation of cancer 
health literacy as a latent variable, with high precision. Total scores range from 0 – 30 with 
higher scores indicating higher health literacy. The mean raw CHLT-30 scores were 23.97 
(+5.61), 24.26 (+5.19), 20.04 (+5.58), and 26.61 (+3.38) for men, women, non-Hispanic 
Blacks, and non-Hispanic Whites, respectively. External validation to determine the extent 
to which CHLT-30 scores predicted self-confidence about engaging in health decisions 
showed the CHLT-30 to be a significant predictor of self-confidence about engaging in 
health decisions (p<.001).18 
The CHLT-30 has large discrimination parameters (mean=.84; median=.79; 
range=.49 to 1.36), as well as moderate to high item-corrected total correlations (mean=.42; 
median=.42; range=.31 to .54). Furthermore, the percent correct item responses were high 
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(mean=.81; median=.84; range=.56 to .93) and the item difficulty parameter estimates were 
all negative (p<.001; mean=-1.43; median=-1.53; range=-2.13 to -0.36), indicating that the 
items are relatively easy to answer. In addition, the CHLT-30 has excellent reliability 
characteristics, with a Cronbach’s alpha of 0.88, 2-week test–retest reliability of 0.90, and 
6-month test–retest reliability of 0.92. Furthermore, CHLT-30 scores showed no gender or 
racial/ethnic bias, even though Black patients’ mean cancer health literacy score was 
significantly lower than that of Whites.18 
In 2016, Echeverri et al. published a study describing the validation of a Spanish 
CHLT-30 version in 400 self-identified, Spanish-speaking, healthy Latinos. The majority 
of participants were from Central America (80.3%), between 25-55 years old (72.8%), and 
had a high school diploma or higher (61.8%). Study results were consistent with those 
obtained in the original validation study by Dumenci et al., 2014, confirming a 
unidimensional factor structure of the instrument. In addition, results showed similar 
internal consistency reliability estimates, and found significant differences in total scores 
by educational level. These results support the application of the Spanish CHLT-30 to 
assess cancer health literacy in healthy Spanish-speaking populations.118 
 
Cancer Health Literacy Tool 6-item (CHLT-6) 
The CHLT-6 is a cancer-specific health literacy tool which differentiates between 
patients with limited cancer health literacy and those with adequate cancer health literacy 
with a high degree of precision. It is highly correlated to the CHLT-30. The CHLT-6 can 
be used to differentiate between patients with limited CHL and those with adequate CHL 
based on responses to the six items. In the study by Dumenci et al., data from 1,306 cancer 
patients showed the average probability of belonging to the limited cancer health literacy 
class and adequate health literacy class to be 0.95 and 0.96, respectively in comparison to 
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a hypothetical gold standard probability of 1.0. This indicates that the accuracy of CHLT-
6 is extremely high. There were also no gender or racial/ethnic biases found in the CHLT-
6 scores. External validity analysis results showed that race/ethnicity, education, and 
income were significant predictors of whether or not an individual would have adequate 
cancer health literacy. Compared to individuals with adequate cancer health literacy, 
individuals with limited cancer health literacy were likely to be Black, under-educated, 
have low income, not be privately insured, and tended not to engage in health decisions.18 
 
2.3 Patient Activation 
Patient engagement is a broad concept that includes patient activation, the 
interventions designed to improve patient activation, and patients’ behavior as result of 
such interventions. Patient activation itself, refers to a patient’s understanding of his/her 
role in the healthcare process and the possession of knowledge, confidence, and skills to 
facilitate active participation in managing their health. This motivates a patient to become 
engaged by taking preventive actions, collaborating with providers, managing symptoms 
and problems, and finding and using high-quality and appropriate care.22-24 Patient 
activation is a measurable  intermediate outcome of care that is linked with health 
outcomes.22  
 
2.3.1 Patient Activation Measure (PAM) 
Patient activation is not a dichotomous variable that either exists or does not exist 
in different patients. It is a latent construct that can be measured on a continuous scale 
using the patient activation measure (PAM), and it changes over a patient’s life course.  
The PAM is a series of questions that estimate an individual's self-concept as a 
manager of his or her health and health care, with response options that are degrees of 
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agreement or disagreement. It was developed by Hibbard et al. in the early 2000s and is an 
interval-level, developmental, unidimensional, and probabilistic Guttman-like scale. The 
PAM enables the assessment of an individual’s knowledge, skills, beliefs and confidence 
for managing his or her health and healthcare.24,25   
The PAM was originally designed as a 22-item Guttman-scale with four levels of 
activation. It measures the confidence, knowledge, and skills that patients have to manage 
their health/health condition(s). In the first activation level, patients take no active steps to 
be involved in their healthcare. In the second activation level, patients possess the 
knowledge and have confidence to be partners in managing their health but take no action. 
In the third activation level, patients are proactive in maintaining and improving their 
health. In the fourth activation level, patients remain partners in managing their health even 
when faced with stress.24 
In 2005, Hibbert et al. developed a 13-item short form of the original PAM. The 
scores on this shorter version were identical to those from the 22-item version ranging from 
38.6 to 53.0 on a theoretical 0 to 100-point scale. Like the 22-item measure, this short 
version was designed to be used in a clinical setting and its infit and outfit values also fell 
between the acceptable range of 0.5 to 1.5. However, there was some loss of precision with 
the 13-item version, which showed a lower reliability for individuals without chronic 
diseases, those 85 years and above, those with lower socioeconomic status and those with 
self-rated poor health. However, these lower scores still fell within the acceptable range.31 
In addition to its usefulness in determining activation levels, the PAM can also be 
employed to evaluate tailored interventions designed to move patients from one level of 
activation to another.24 
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PAM Psychometric Properties 
The psychometrics of this scale, when tested in a convenience sample of 486 
individuals (n = 118 without chronic disease), showed comparable reliability statistics for 
those with disease and without disease. The Rasch analysis was used to test the 
psychometric properties of this instrument. In this analysis, item selection is based on item 
fit statistics which represent how much the item responses deviate from the model’s 
expectations. The infit value is most sensitive to item fit for an item whose scale location 
is close to the respondent’s location, while the outfit value is more sensitive to item fit 
when an item’s scale location is distant from the respondent’s scale location. Item fit values 
between 0.5 and 1.5 indicate sufficient unidimensionality and expected response variability 
for a rating scale measurement.24 
The items in the PAM scale had infit values (0.76 to 1.32) which were within the 
range for a unidimensional measure. The 22-item Rasch person reliability ranged from 0.85 
(real) to 0.88 (model) and the Cronbach’s alpha was 0.91. The PAM also showed a high 
level of reliability when further testing was done in a national probability survey (N = 
1,515). Infit values ranged from 0.71 to 1.44 while the outfit statistics (except one) ranged 
from 0.80 to 1.34. In addition, the PAM had high degrees of construct and criterion 
validity.24 
 
2.3.2 Patient Activation and Health Outcomes 
Activated patients understand that apart from the care and support of medical 
practitioners, the sustenance of good health depends on their knowledge of their disease 
condition, the possession of skills to manage their symptoms and the confidence to take 
appropriate action when necessary.   
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Patients with low activation are twice as likely to delay medical care, and three 
times more likely to have unmet medical needs in comparison to patients with high 
activation.29 In addition, patients that are highly activated are at least two times as likely to 
prepare questions for a physician visit, to know about treatment options for their disease, 
to seek health information, and to compare the quality of health care received from 
providers compared to patients with low activation.30,31 Challenging behaviors are less 
likely to be adopted by patients with low activation, therefore, tailoring interventions to 
patients’ activation level by encouraging realistic behavior has a greater chance of 
successfully increasing their level of activation.23  
Studies have provided evidence that patients who have high activation levels have 
better health outcomes and place a lower burden on the health system with fewer 
hospitalizations and less emergency department visits.25-28 Patient activation is a 
modifiable factor and interventions tailored to individual patients’ activation level have 
been shown to be effective in increasing patient activation. However, patients with the 
lowest activation tend to have greater improvements in activation when interventions are 
introduced compared to patients who already have high activation levels (ceiling 
effect).22,32-34 
Compared to Caucasians and African Americans, Hispanics have much lower 
levels of patient activation with only 24.8 percent of Hispanics at the highest level of patient 
activation (activation level 4), compared to 39.5 percent of blacks and 45.3 percent of 
whites. Low acculturation and ability to navigate the American healthcare system have 
been identified as contributory factors to these differences which persist even after 
controlling for other demographic and socioeconomic factors. In addition, Hispanic breast 
cancer patients have the greatest odds for decision dissatisfaction and are more vulnerable 
to poor breast cancer treatment decision outcomes than patients of other ethnicities. 
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Consequently, increased patient activation among this patient population might 
significantly reduce disparities in their access to healthcare.35,36 
Irrespective of disease type and economic level, highly activated patients have 
greater adherence to treatment regimens and are more likely to regularly perform self-
monitoring as well as obtain regular chronic disease care.25,31,37-39 A number of studies have 
examined the impact of improved activation in patients with different chronic diseases such 
as diabetes, depression, HIV and hypertension and the results of these studies show the 
financial, clinical, and psychological benefits of such interventions.40-42  
 
2.3.3 Patient Activation in Chronic Disease States 
In a 2013 study, Marshall et al. investigated the association between patient 
activation and health outcomes in HIV-infected individuals. The cross-sectional study was 
conducted among 433 patients in four different clinics using the 13-item PAM, CD4 
counts, viral load counts and patient-reported adherence. Study results revealed that patient 
activation was high overall, with an average PAM score of 72.3+ 16.5. Multivariate models 
showed that every 5-point increase in PAM scores was associated with greater odds of 
adherence, viral suppression and CD4 count >200 cells/ml. They concluded that patient 
activation improved patient adherence and consequently led to more efficient viral 
suppression.41 
In another study, Kukla et al. also studied the relationship between patient 
activation and disease outcomes in schizophrenic patients. A total of 119 patients were 
enrolled in a randomized control trial for 18 months. Patient activation was measured using 
the 13-item mental health version of the PAM, psychiatric symptoms were measured using 
the 30-item Positive and Negative Syndrome Scale (PANSS) and medication adherence 
was measured with the 4-item Morisky scale. The mean PAM score of study participants 
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was moderate (55.6 + 16.0). The results revealed that positive recovery attitudes, higher 
levels of hope and fewer emotional discomfort symptoms were associated with higher 
patient activation scores. However, there was no link between medication adherence and 
patient activation in this group of patients.119 
A systematic review conducted by Kinney et al. revealed an inverse relationship 
between patient activation scores and hospitalizations.120 In particular, chronic 
cardiopulmonary disease patients had increasingly higher rates of 30-day post discharge 
re-hospitalization as activation scores decreased. Compared with activation level 4 patients 
(highest activation scores), patients in activation level 3, 2, and 1 had 1.30, 1.50, and 1.75 
times higher rates of re-hospitalization, respectively. A similar trend was also revealed for 
emergency department visits.27,120,121 
Remmers et al. also investigated the ability of PAM scores to predict future health 
outcomes in diabetes patients, using a multivariate logistic regression. Study results 
revealed that the PAM was predictive for hemoglobin A1c testing, low-density lipoprotein 
cholesterol (LDL-C) testing, and hemoglobin A1c control. However, it was not predictive 
for lipid lowering drug use, LDL-C control or acute myocardial infarction discharges. They 
concluded that patients at risk for poorer health outcomes could be identified using PAM 
scores.26 
Lastly, O’Malley et al. investigated the determinants of patient activation in a 
predominantly Caucasian (77%) and African American (15%) cohort of breast and prostate 
cancer survivors. The response option of the PAM was modified to range from 1 to 4 with 
higher scores indicating greater patient activation. The study results revealed that among 
the 213 breast cancer survivors, overall patient activation was high with a mean of 
3.34±0.37 and this was significantly higher than that of the 112 prostate cancer survivors 
(3.25±0.38). Race, marital status, employment status, household income, and fear of 
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recurrence were significantly associated with patient activation for only prostate cancer 
survivors. However, for both breast and prostate cancer survivors, ease of access to and 
perceptions of time spent with healthcare providers (oncology team and primary care 
physicians) were positive predictors of activation.43 
Patient activation has also been shown to affect the behaviors and experiences of 
cancer survivors. Highly activated cancer survivors are more likely to feel that values are 
reflected in their treatment plans and they are more likely to adequately handle side effects 
than less activated patients. On the other hand, less activated patients are less likely to 
understand their diagnosis, follow treatment regimens, or be satisfied with their care.122 
 
2.3.4 Health Literacy and Patient Activation 
Patient activation and health literacy are independent predictors of health and 
deficits in either of them could serve as targets for behavioral intervention.44,45 Higher 
activation helps individuals with low literacy and numeracy abilities to compensate for 
their lower skills and to achieve higher levels of comprehension. When health trade-offs 
are necessary, making the right choice depends on literacy and comprehension as well as 
patient activation.46 
A study by Hibbard et al. investigating the relationship between patient activation 
and health literacy showed that among older adults, both health literacy and patient 
activation were significantly and positively related to healthcare decision making, even 
though this relationship was stronger for health literacy. Patient activation had slightly 
stronger relationships to health-care-related behaviors, healthy behaviors, and self-
management behaviors than health literacy.47 Another study by Nijman et al. which 
examined the relative contribution of patient activation and functional health literacy to the 
seeking and use of health information showed that more activated consumers were more 
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likely to seek and use health information. In the study sample, health literacy increased as 
patient activation increased, with a weak to moderate overall correlation between the health 
literacy and activation scores.48  
Recent studies in oncology reveal that health literacy and certain aspects of patient 
activation are correlated. A cross-sectional, multicenter oncology study examined patient 
activation, health literacy, symptom burden, confidence to self-manage side effects, and 
medication adherence to oral oncolytics. Results showed that confidence to self-manage 
side effects (e.g., fatigue and diarrhea) were associated with higher health literacy and 
higher patient activation.49 Another study revealed that higher patient activation increases 
colorectal cancer screening in low income, minority patients with limited health literacy 
skills.50 However, these studies were conducted in homogenous patient populations (95% 
Caucasian), were not specific to breast cancer patients, or did not illustrate the relationships 
of patient activation and health literacy to health outcomes and resource utilization. 
 
2.4 Theoretical framework 
The health literacy skills (HLS) framework put forth by Lee et al. in 2004 will be 
used in this study.123 The HLS framework (Figure 2.1) describes how health literacy affects 
health outcomes through intermediate factors. It also depicts the net effects of health 
literacy and intermediate variables. The intermediate factors linking health literacy to 
health outcomes include disease and self-care knowledge, health risk behavior, preventive 
care and physician visits, and compliance with medications. The health outcomes are health 
status, emergency care, and hospitalization, while the moderators/control variables 
include gender, ethnicity, socioeconomic status, health insurance coverage, disease 
severity, and income.123 
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Specifically, the HLS framework posits that individuals with lower health literacy 
are likely to have poorer medical knowledge, worse health behavior, less regular preventive 
care and physician visits, and poorer compliance with routine clinical visits and 
medications. These factors, in turn, may delay seeking timely and appropriate care, produce 
poor health outcomes, and increase the use of emergency and hospital services. In testing 
the relationships between variables, important confounders including socioeconomic 
status, educational level, age, gender, ethnicity, health insurance coverage, disease severity, 
and income serve as control variables.123 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1: Health Literacy Skills Framework123 
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Studies have consistently shown that patients with diabetes, asthma, hypertension, 
HIV/AIDS, and cancer who have low health literacy are less knowledgeable about their 
disease and less capable of adequate self-care.102,124-126 Furthermore, such patients with less 
knowledge of disease management are likely to have lower health status and suffer from 
more severe illnesses, leading to more emergency department visits and hospitalizations.123 
Increasing health literacy tends to improve self-reported health status, lower healthcare 
costs, increase health knowledge, shorten hospitalizations, and decrease use of healthcare 
services.88,127-129  
Cho et al. explored disease knowledge, health behavior, preventive care, and 
compliance as potential intermediate factors which could link health literacy with health 
status and utilization. Study participants consisted of 489 elderly Medicare patients who 
completed face-to-face interviews between March 2003 and February 2004. The majority 
of participants were female (78.7%), African American (59.1%), and had an average 
education equivalent to a high school diploma. Health literacy was measured using the 
Short Test of Functional Health Literacy in Adults (S-TOFHLA) and 29 other items 
measured disease knowledge, health behavior, preventive care, medication compliance, 
and health status. Health care utilization was assessed by asking participants the number of 
emergency room visits and the number of hospital admissions they had in the previous 
year. Study results showed that health literacy was significantly and positively correlated 
with health status (r = 0.50) as well as the four intermediate factors of disease knowledge 
(r = 0.38), health behavior (r = 0.42), preventive care (r = 0.21), and medication 
compliance (r = 0.20). Conversely, health literacy was negatively correlated to healthcare 
utilization.130 
Another study by Halverson et al. examined the association of HRQoL and health 
literacy among a registry-based statewide sample of 1,841 newly diagnosed breast, lung, 
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prostate, and colorectal cancer patients in Wisconsin. Sociodemographic and clinical data 
were obtained from the state’s cancer registry, while health literacy and HRQoL were 
measured with a mailed questionnaire consisting of a cancer-specific quality of life 
instrument (FACT-G) and four self-report items measuring health literacy on a 5-point 
Likert scale. The survey respondents were mostly non-Hispanic Whites (93%) and female 
(50.8%) with a mean age of 63.2 (±10.7). Study results showed that higher health literacy 
was significantly associated with greater HRQoL. Controlling for covariates, there were 
also significant differences between those in the highest and lowest health literacy 
categories and in the four quality of life subscales (physical, functional, emotional, social) 
of the FACT-G. They concluded that health literacy is positively and independently 
associated with HRQoL among cancer patients. Such findings suggest the need to take the 
health literacy level of cancer patients into account in the course of disease management as 
tailored communication regarding the risks and benefits of tests and treatments may be 
beneficial in this population.11 Other health outcomes resulting from higher health literacy 
included patient acquisition of new knowledge, more positive attitudes, greater self-
efficacy, and positive health behaviors.131 
It has been hypothesized that health literacy influences health outcomes through three main 
mechanisms:132  
 Healthcare access and utilization which are influenced by navigation skills, self-
efficacy and perceived barriers. 
 Patient-provider interactions which are influenced by knowledge, beliefs and 
participation in decision-making.  
 Self-care which is influenced by motivation, problem-solving, self-efficacy, 
knowledge, and skills. 
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The factors that influence self-care are embodied in patient activation, which is a 
compound construct that represents the confidence, knowledge, and skills that individuals 
have to manage their health and healthcare.133 Therefore, disease self-care/knowledge, a 
key component of patient activation, is the intermediate factor of interest in the proposed 
model. Patient activation has been shown to mediate the relationship between health 
literacy and health outcomes.134 The influence of health literacy on the outcome variables 
via patient activation, controlling for covariates, will be investigated in this study. Figure 
2.2 depicts the specific framework that will be employed.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2: Health Literacy Skills Framework in Breast Cancer Patients 
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2.5 Study significance  
Compared to individuals with poor health literacy levels, those with high health 
literacy have significantly lower predicted values of office visit expenditures ($719 vs 
$1,284) and emergency department visit expenditures ($100 vs $151).135 Also, patients 
with high activation levels have better health outcomes and place a lower burden on the 
health system with fewer hospitalizations and less emergency department visits.25-28 
However, only a few studies have examined the relationship of both patient activation and 
health literacy with health outcomes to date,44,47 and no known studies have investigated 
this relationship in breast cancer patients.  
Health literacy is closely related to an individual’s ability to use information to 
make health-related decisions while patient activation is more closely aligned with health 
outcomes such as chronic disease self-management. Though similar, both constructs are 
unique predictors of health47  
The majority of studies that have examined health literacy and patient activation in 
breast cancer patients have primarily focused on disease screening/detection. The common 
instruments (REALM and TOFHLA) used to assess health literacy in cancer patients 
primarily assess reading proficiency and word recognition. In addition, there is little 
evidence of the association between TOFHLA or REALM scores and cancer patient 
engagement in health decisions.18,136 This is a major limitation of these instruments because 
the ability to make appropriate health decisions is the primary outcome of health literacy. 
Also, these instruments are probably not sensitive to cancer-specific literacy because of the 
complex treatment choices that cancer patients face, coupled with the increased demand 
for self-care.18,87,136  
Furthermore, the only known study that has investigated patient activation in cancer 
survivors used a mixed population of breast and prostate cancer survivors to assess rates 
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of patient activation as well as explore the demographic and clinical characteristics 
associated with activation in the population.43 There is still an unmet need to assess health 
literacy in patients with a confirmed breast cancer diagnosis using a cancer-specific 
instrument and also to examine its association with patient self-ability to manage health 
and breast cancer-relevant health outcomes. In addition, it might be useful to explore how 
the recently developed cancer-specific health literacy tool (CHLT-6) compares with a 
general health literacy instrument (NVS) that assesses math, reading, and comprehension 
skills as well as abstract reasoning, and whose specificity is comparable to that of widely 
used health literacy measures. 
The aim of this study was to assess health literacy and patient activation in HER-2 
positive breast cancer patients as well as examine their relationships to health outcomes. 
The findings of this study could inform and facilitate the provision of activation level-
appropriate information to breast cancer patients at their literacy level, thereby increasing 
the effectiveness of interventions to improve patients’ involvement in managing their 
health. This would enhance the ability of health care providers and policy-makers to 
personalize the delivery of care for breast cancer patients, resulting in improved quality of 
life and less utilization of limited healthcare resources.  
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Chapter 3: Methodology 
The purpose of this study was to assess cancer health literacy and level of patient 
activation in a sample of HER-2 positive breast cancer patients as well as examine the 
relationship between these two constructs and their influence on health outcomes. This 
chapter outlines the study design, study objectives and hypotheses, study variables, study 
sample, enrollment protocol, data collection, and statistical analyses. 
 
3.1 Study Design 
A prospective, cross-sectional study design was used to achieve the study 
objectives. A single survey consisting of 67 items (Appendix 1) was used to collect data 
from HER-2 positive breast cancer patients receiving chemotherapy in selected Texas-
based oncology clinics. HER-2 positive breast cancer patients were the target study sample 
because they typically have office visits for the receipt of chemotherapy and/or targeted 
therapy treatment. Therefore, these patients could participate in the study during their 
office visits.  
The selected oncology clinics are part of a larger practice consisting of over 460 
physicians in 210 locations throughout Texas and southeastern Oklahoma. In addition to 
adopting a community-based approach to oncology care, this practice participates in value-
based care models, including the Oncology Care Model (OCM), which are designed to 
improve patient care and the cancer treatment experience. These care models help patients 
to better understand their illness and treatment, manage treatment side effects, and avoid 
unnecessary hospital and emergency room visits.137,138  
The survey used in this study was pre-tested with three breast cancer patients. 
During regular clinic visits, eligible patients were offered participation in the study by 
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clinic staff. Patients who give their consent to participate were asked to complete a self-
reported survey (Appendix 1) consisting of the 6-item cancer health literacy tool (CHLT-
6), the 6-item newest vital sign (NVS), the 13-item patient activation measure (PAM 13), 
the 27-item functional assessment of cancer therapy (FACT-G v. 4), two items measuring 
the quality of patient-provider communication, and single item measures for the number of 
breast cancer-related emergency department visits, and  hospitalizations, as well as clinical 
and demographic patient characteristics.  
 
3.2 Study objectives and hypotheses 
The objectives of this study and corresponding hypotheses are as follows: 
1. To describe health literacy, patient activation, clinical (stage of breast cancer at 
diagnosis, time since diagnosis, type of breast cancer treatment received, 
comorbidities) and demographic (age, gender, educational level, ethnicity, 
household income, insurance status, marital status) characteristics of a breast cancer 
patient sample. 
2. To examine the relationships between health literacy and clinical and demographic 
characteristics in a sample of breast cancer patients. 
3. To examine the relationships between patient activation and clinical and 
demographic characteristics in a sample of breast cancer patients. 
4. To assess the relationship between cancer health literacy and patient activation in a 
sample of breast cancer patients. 
H1: Breast cancer patients who have adequate cancer health literacy will have 
higher patient activation compared to those that have limited cancer health literacy. 
5. To examine the relationship between cancer health literacy and patient-provider 
communication in a sample of breast cancer patients. 
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H2: Breast cancer patients who have adequate cancer health literacy will have 
easier patient-provider communication and understanding of information provided 
compared to those that have limited cancer health literacy. 
6. To assess the relationship between cancer health literacy and general health literacy 
in a sample of breast cancer patients. 
H3: There will be a significant positive relationship between cancer health literacy 
and general health literacy in the sample of breast cancer patients. 
7. To determine the overall predictive validity of the health literacy skills (HLS) 
framework in explaining health outcomes (cancer health-related quality of life, 
cancer-related emergency department visits, and cancer-related hospitalizations) 
using cancer health literacy and patient activation, controlling for cancer health 
literacy X patient activation interaction and clinical/demographic characteristics.  
H4: Cancer health literacy and patient activation will explain a significant amount 
of variance in cancer health-related quality of life controlling for the interaction 
between cancer health literacy and patient activation as well as clinical and 
demographic characteristics. 
H5: Cancer health literacy and patient activation will explain a significant amount 
of variance in cancer-related emergency department visits controlling for the 
interaction between cancer health literacy and patient activation as well as clinical 
and demographic characteristics. 
H6: Cancer health literacy and patient activation will explain a significant amount 
of variance in cancer-related hospitalizations controlling for the interaction 
between cancer health literacy and patient activation as well as clinical and 
demographic characteristics. 
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8. To predict cancer health-related quality of life in breast cancer patients using cancer 
health literacy and patient activation controlling for the interaction between cancer 
health literacy and patient activation as well as clinical and demographic 
characteristics. 
H7: Cancer health literacy and patient activation will be significant positive 
predictors of cancer health-related quality of life controlling for the interaction 
between cancer health literacy and patient activation as well as clinical and 
demographic characteristics. 
9. To predict cancer-related emergency department visits in breast cancer patients 
using cancer health literacy and patient activation controlling for the interaction 
between cancer health literacy and patient activation as well as clinical and 
demographic characteristics.  
H8: Cancer health literacy and patient activation will be significant negative 
predictors of cancer-related emergency department visits controlling for the 
interaction between cancer health literacy and patient activation as well as clinical 
and demographic characteristics. 
10. To predict cancer-related hospitalizations in breast cancer patients using cancer 
health literacy and patient activation controlling for the interaction between cancer 
health literacy and patient activation as well as clinical and demographic 
characteristics.  
H9: Cancer health literacy and patient activation will be significant negative 
predictors of cancer-related hospitalizations controlling for the interaction between 
cancer health literacy and patient activation as well as clinical and demographic 
characteristics. 
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3.3 Study Variables 
The primary independent variable in this study is cancer health literacy while 
patient activation is the secondary independent variable. Dependent variables include 
cancer health-related quality of life, number of cancer-related ED visits, number of cancer-
related hospitalizations, and quality of patient-provider communication. Measures for each 
variable are discussed in detail below. 
 
3.3.1 Independent Variables 
Cancer Health Literacy (CHL) 
Health literacy is defined as the degree to which an individual can obtain, 
communicate, process, and understand basic health information and services needed to 
make appropriate health decisions.87  The 6-item cancer health literacy tool (CHLT-6) is a 
cancer-specific health literacy tool which was developed by Dumenci et al. in 2014 to 
measure the health literacy of cancer patients (items 1 – 6 in Appendix 1).18 
The CHLT-6 can be used to differentiate between patients with limited CHL and 
those with adequate CHL based on responses to the six items. Each item has only one 
correct response option which is scored as one while incorrect option(s) are scored as zero. 
There are 64 possible response patterns for the six items and each pattern has a specific 
probability of adequate and inadequate CHL, which sum up to unity. A patient’s CHL is 
identified by choosing the CHL with the higher probability based on his or her response 
pattern. For example, a response pattern of 001001 to the six items has a 0.88 probability 
of limited CHL and a 0.12 probability of adequate CHL. Therefore, patients with this 
response pattern will be considered to have limited CHL.  On the other hand, a response 
pattern of 111011 to the six items has a 0.17 probability of limited CHL and a 0.83 
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probability of adequate CHL. Therefore, patients with this response pattern will be 
considered to have adequate CHL.18 
During its development, data from 1,306 cancer patients showed the average 
probability of belonging to the limited CHL class and adequate CHL class to be 0.95 and 
0.96, respectively. Compared to the hypothetical gold standard probability of 1.0, this 
indicates that the accuracy of CHLT-6 is extremely high. The large differences in the 
probability of correct responses to the six items between adequate and limited CHL classes 
also indicate that the CHLT-6 separates patients with limited CHL from those with 
adequate CHL with a high degree of precision.18 
In addition, there were no gender or racial/ethnic bias found in CHLT-6 scores for 
this sample. Multigroup latent class analysis was used to test gender and racial/ethnic bias. 
Results supported the measurement invariance in both gender and racial/ethnic groups, 
providing evidence that CHLT-6 scores were free from bias. External validity analysis 
results also showed that race/ethnicity, education, and income were significant predictors 
of whether or not an individual would have adequate CHL.18 
 
General Health Literacy 
The Newest Vital Sign (NVS) was developed by Weiss et al. in 2005 to assess the 
level of general health literacy in the primary care setting. The NVS uses an ice-cream 
nutrition label and six open-ended questions to assesses math, reading, and comprehension 
skills as well as abstract reasoning (items 7 – 12 in Appendix 1).17 This instrument takes 
approximately three minutes to be administered either face-to-face or in the paper/pencil 
format.17,139,140 Total scores range from 0 to 6 with higher scores indicating higher general 
health literacy. Patients who answer at least four questions correctly on the NVS are 
considered to have adequate health literacy while those who answer less than four questions 
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correctly most likely have limited health literacy. The NVS has good sensitivity and might 
be more sensitive than the TOFHLA to marginal health literacy. In addition, its specificity 
is similar to or better than that of other widely used clinical screening methods.17 
 
Patient Activation 
Patient activation is defined as the confidence, skill and knowledge that patients 
possess which determine the level of their participation in managing their disease. It is 
measured using the patient activation measure (PAM) which categorizes patients into four 
levels of activation based on their total score.133 The PAM is an interval level, 
unidimensional, 13-item instrument which measures a patient’s willingness and ability to 
manage his/her health and healthcare (Figure 3.1). It has been shown to be a highly reliable 
and valid instrument. Rasch analysis shows that the 22-item PAM scale has infit (0.71 to 
1.44) and outfit (0.80 to 1.34) values within the normal range of 0.5 to 1.5. Also, the 22-
item Rasch person reliability ranges from 0.85 (real) to 0.88 (model) and the Cronbach’s 
alpha is 0.91. The psychometric scores of the 13-item scale are similar to that of the 22-
item version. The PAM-13 items have a calibrated scale range from 38.6 to 53.0, which is 
comparable with the PAM-22 item range of 38.3 to 54.5. The infit and outfit statistics for 
the PAM-13 items also fall within the acceptable scale range of 0.5 to 1.5. The statistically 
significant relationships (p<0.001) between the PAM scores and conceptual variables (such 
as preventive behaviors, disease-specific self-management behaviors, and consumeristic 
behaviors) are evidence of the scale’s construct validity.133,141  
Patient activation as outlined in the PAM involves four progressive levels of patient 
activation (Figure 3.1). Patients in activation level 1 usually do not feel in charge of their 
own health. These patients tend to lack basic knowledge about their condition as well as 
confidence in their ability to manage their health. Increasing these patients’ activation level 
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involves getting them to realize that they have an active role to play in managing their 
health.  
Patients in activation level 2 tend to have some knowledge about their condition, 
treatment options, and/or self-care, even though large gaps remain. These patients have 
little experience or success with behavior change. Increasing activation in level 2 patients 
involves improving their knowledge of their disease condition and its management, as well 
as increasing their confidence to take action when symptoms arise.  
Activation level 3 patients generally understand the key facts of their condition and 
treatment as well as some experience and success in making behavioral changes. They also 
have some confidence in handling limited aspects of their health. Increasing activation in 
this level involves increasing patients’ confidence and ability to manage all aspects of their 
illness by building on their past experience and successes 
Patients in activation level 4 have typically made most of the necessary behavior 
changes with regards to managing their health but may have difficulty in being consistent 
over time, or during times of stress. For these patients, it is important to increase their 
confidence and skills for maintaining behaviors and coping with stress, even in the 
presence of routine stressors or when there is a change in their disease severity.  
Item scale locations can be converted from the original scale to a theoretical 0–100 
point scale using the PAM-13 scoring spreadsheet. Total scores on the 13-item PAM range 
from 38.6 to 53.0, with higher scores signifying greater activation.141 See Appendix 1, 
items 13 to 25 for the scale items. 
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Figure 3.1: Patient Activation Measure with Item Calibrations and Four Activation 
Levels Identified 
 
3.3.2 Dependent Variables 
Health-Related Quality of Life (HRQoL) 
HRQoL is a multi-dimensional concept that measures an individual’s perception of 
his or her own health. It includes physical, mental, emotional, and social functioning 
domains which collectively describe the impact of health status on quality of life.142 The 
functional assessment of cancer therapy, general version 4 (FACT-G v. 4) is considered to 
be a standard assessment of HRQoL in cancer patients. This self-administered instrument 
consisting of 27 items (items 26 – 52 in Appendix 1) measures quality of life over the last 
seven days pertaining to four areas:143,144 
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1. Physical well-being – 7 items 
2. Social/family well-being – 7 items 
3. Emotional well-being – 6 items 
4. Functional well-being – 7 items 
Responses to each item are on a 5-point Likert scale ranging from 0 (not at all) to 
4 (very much) with higher numbers indicating a better health state. Scores can be generated 
for each sub-scale provided that more than 50 percent of the items comprising the subscale 
are answered. A subscale score is computed as the prorated sum of the item responses for 
that subscale. Missing values are replaced with the mean of completed items for that 
subscale. Subscale scores range from 0 – 28 for physical, social/family, and functional 
well-being, while emotional well-being scores range from 0 – 24. The FACT-G v. 4 total 
score ranges from 0 – 108 and is computed as the sum of the four subscale scores, provided 
that at least 80 percent of the 27 items were answered. Negatively worded items are reverse 
scored prior to summing so that higher subscale and total scores indicate higher 
HRQoL.145,146  
The original FACT-G version was validated in a mixed cancer patient population 
that included breast, colorectal, and lung cancer patients. It has evidence of reliability, 
validity, and responsiveness. In addition to test-retest reliability and responsiveness, it can 
discriminate between patients based on disease stage, performance status rating, and 
hospitalization status. It is sensitive to change over time and compares well to other scales 
measuring similar constructs like the Functional Living Index of Cancer (FLIC) and 
Eastern Cooperative Oncology Group (ECOG) performance status rating. There is also 
differential responsiveness of the FACT-G subscales to groups that differ in physical, 
social, emotional, and functional well-being. 143 
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Number of Cancer-Related Emergency Department (ED) Visits 
One open-ended item was used to measure how often patients sought emergency 
medical care due to breast cancer complications in terms of the number of ED visits in the 
last 30 days: Within the last 30 days, how many times have you had to visit the emergency 
department due to a breast cancer complication? 
Number of Cancer-Related Hospitalizations 
One open-ended item was used to measure how often patients were hospitalized 
due to breast cancer complications in the last 30 days: Within the last 30 days, how many 
times have you been hospitalized due to a breast cancer complication? 
Quality of Patient-Provider Communication 
 Two items with five response options on a Likert scale were used to assess the 
quality of patient-provider communication: 1) How difficult is it for you to communicate 
your concerns about your breast cancer to your healthcare provider(s); and 2) How difficult 
is it for you to understand the information provided by your healthcare provider(s) about 
your breast cancer? 
 
3.3.3 Patient Demographic and Clinical Variables 
Single items were used to measure the demographic and clinical characteristics of 
study participants. Age, gender, educational level, ethnicity, household income, insurance 
status, marital status, stage of breast cancer at diagnosis, type(s) of breast cancer 
treatment(s) received, time since diagnosis, and comorbidities. 
Table 3.1 contains a summary of all the variables that were used in the study, their 
operational definitions and the number of items that measured each variable. 
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Table 3.1: Constructs and Operational Definitions 
Construct Operational definition Item(s) 
Independent variables 
Cancer health 
literacy 
The 6-item cancer health literacy tool (CHLT-6) was used to 
measure cancer health literacy. Individuals were considered to 
have adequate or limited cancer health literacy based on their 
responses to the six items.  
6 
General health 
literacy 
The 6-item newest vital sign (NVS) was used to measure 
general health literacy. Patients who answered three or fewer 
questions correctly were considered to have limited health 
literacy while those that answered more than three questions 
correctly were considered to have adequate health literacy.  
6 
Patient activation 
The 13-item patient activation measure (PAM) was adapted to 
measure disease and self-care knowledge/ability in breast 
cancer patients. Total PAM scores range from 0 to 100 with 
higher scores indicating greater patient activation. Patients 
were grouped into four levels of activation based on their PAM 
scores: 
Activation level 1 (≤ 41) coded as 1 
Activation level 2 (> 42 but < 50) coded as 2 
Activation level 3 (50 – 51) coded as 3 
Activation level 4 (> 52) coded as 4 
13 
Dependent variables 
Cancer health 
related quality of 
life (HRQoL) 
The 27-item FACT-G was used to measure cancer HRQoL in 
four subscales: 
1. Physical well-being – 7 items 
2. Social/family well-being – 7 items 
3. Emotional well-being – 6 items 
4. Functional well-being – 7 items 
Responses to each item were on a 5-point Likert scale ranging 
from 0 (not at all) to 4 (very much) with higher scores 
indicating greater HRQoL. Subscale scores ranged from 0 – 28 
for physical, social/family, and functional well-being, while 
emotional well-being scores ranged from 0 – 24. Total FACT-
G score ranges from 0 – 108. 
27 
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Table 3.1: Constructs and Operational Definitions Contd. 
Construct Operational definition Item(s) 
Number of cancer-
related emergency 
department visits 
One open-ended question was used to measure this construct: 
Within the last 30 days, how many times have you had to visit 
the emergency department due to a breast cancer 
complication?  ……………………….. times 
1 
Number of cancer-
related 
hospitalizations 
One open-ended question was used to measure this construct: 
Within the last 30 days, how many times have you been 
hospitalized due to a breast cancer complication?  
 ……………………….. times 
1 
Quality of patient-
provider 
communication 
Two questions were used to measure the quality of patient-
provider communication.  Responses to each item were on a 5-
point Likert scale ranging from 1 (extremely difficult) to 5 
(extremely easy): 
How difficult is it for you to communicate your concerns about 
your breast cancer to your healthcare provider(s)? 
1 = Extremely difficult 
2 = Somewhat difficult 
3 = Neither easy nor difficult 
4 = Somewhat easy 
5 = Extremely easy 
Higher scores indicated easier patient communication with 
healthcare provider(s) 
1 
How difficult is it for you to understand the information prov-
ided by your healthcare provider(s) about your breast cancer? 
1 = Extremely difficult 
2 = Somewhat difficult 
3 = Neither easy nor difficult 
4 = Somewhat easy 
5 = Extremely easy 
Higher scores indicated easier patient understanding of 
information 
1 
Covariates 
Age Year of birth (subtracted from 2018) 1 
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Table 3.1: Constructs and Operational Definitions Contd. 
Construct Operational definition Item(s) 
Gender 
One question with four nominal response options was used to 
measure this construct: What is your gender?    
1 = Male 
2 = Female 
3 = Transgender 
4 = Other (please specify) 
1 
Educational level 
One question with four ordinal response options was used to 
measure this construct: Which option best describes your 
highest education level? 
1 = Less than High School 
2 = High School Graduate or GED 
3 = College graduate 
4 = Postgraduate (e.g., MD, MS, PhD)    
Higher scores indicated a higher educational level 
1 
Ethnicity 
One item with six nominal response options was used to 
measure this construct: Which of the following best describes 
your racial/ethnic background? 
1 = African-American or non-Hispanic black  
2 = American Indian or Alaska Native 
3 = Asian-American or Pacific Islander 
4 = Caucasian or non-Hispanic white 
5 = Mexican-American or Hispanic 
6 = Other (please specify) ……………………… 
1 
Household income  
This construct was measured by a single item with five ordinal 
response options: Which option best describes your annual 
household income? 
1= Less than $25,000 
2 = $25,000 to $50,000 
3 = > $50,000 to $75,000 
4 = > $75,000 to $100,000 
5 = >$100,000 
Higher scores indicated a higher annual household income. 
1 
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Table 3.1: Constructs and Operational Definitions Contd. 
Construct Operational definition Item(s) 
Insurance status 
One item with six nominal response options was used to 
measure this construct: Which option best describes the type of 
health insurance you currently have? 
1 = No insurance/Self-pay 
2 = Private insurance 
3 = Medicare 
4 = Medicaid 
5 = Not sure 
4 = Other (please specify) ………………………………. 
1 
Marital status 
One item with six nominal response options was used to 
measure this construct: Which option best describes your 
marital status? 
1= Single, in a relationship                                         
2 = Single, not in a relationship  
3 = Married                 
4 = Partner/Living together         
5 = Divorced/Separated 
6 = Widowed 
1 
Stage of breast 
cancer at diagnosis 
One item with six response options was used to measure this 
construct: At what stage was your breast cancer diagnosed? 
1 = Stage 0 
2 = Stage 1 
3 = Stage 2 
4 = Stage 3 
5 = Stage 4 
6 = Do not know 
1 
Time since breast 
cancer diagnosis 
One item with four ordinal response options was used to 
measure this construct: How long ago were you first diagnosed 
with breast cancer? 
1 = 1 year or less 
2 = More than 1 year but less than 5 years 
3 = More than 5 years but less than 10 years 
4 = More than 10 years 
Higher scores indicated a longer time since breast cancer 
diagnosis. 
1 
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3.4 Sample Size Calculation 
Assuming a medium effect size and an alpha of 0.05, and power of 0.80, the sample 
size needed to conduct the analyses is:  
Multiple linear regression 
1. Overall model significance 
N  50 + 8m   
m = 13 because of the number of independent variables (2) and covariates (11) 
N > 50 + 8 (13) 
Table 3.1: Constructs and Operational Definitions Contd. 
Construct Operational definition Item(s) 
Type(s) of breast 
cancer treatment(s) 
received  
One item with four nominal responses was used to measure 
this construct: Besides chemotherapy, what other type of breast 
cancer treatment have you received? Check all that apply. 
1 = Surgery 
2 = Hormone therapy 
3 = Radiation therapy 
4 = Other (please specify) ………………………………. 
1 
Comorbidities 
One item with eleven nominal responses was used to measure 
this construct: In addition to breast cancer, what other illnesses 
do you have? Check all that apply.  
1 = Asthma 
2 = Arthritis 
3 = Diabetes 
4 = Hypertension 
5 = Hypercholesterolemia 
6 = Kidney problems 
7 = Heart disease 
8 = Anxiety 
9 = Depression 
10 = Thyroid problems 
11 = Other (please specify) ………………………………. 
1 
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N > 50 + 104 
N > 154 
2. Individual predictors 
N  104 + m 
m = 13 
N > 104 + 13 
N > 117 
Therefore, a sample size of 154 HER-2 positive breast cancer patients was needed to 
achieve the study objectives. 
 
3.5 Enrollment and Data Collection  
Using continuous enrollment, the clinic’s research staff recruited breast cancer 
patients who met the inclusion/exclusion criteria via convenience sampling, when they 
showed up for routine clinic visits. Clinic research staff already had human subjects 
training and those involved in the study were trained on the study protocol prior to patient 
recruitment. Patients who expressed willingness to participate were assigned a unique 
study identification number and given the survey cover letter (Appendix 2) and survey 
instrument by clinic research staff while waiting to see their physician/healthcare provider. 
The number of patients who were asked but did not consent to participate in the study were 
also recorded by clinic staff using the informed consent tracking log (Appendix 4). 
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3.5.1 Inclusion Criteria 
The following criteria were applied for study inclusion:  
 Adult (age 18 years through 80 years) HER-2 positive breast cancer patients who 
were receiving chemotherapy/HER2 directed therapy from selected Texas 
Oncology clinics; 
 Patients who had a scheduled office appointment between August and October 
2018; and 
 Patients who expressed willingness and give their consent to participate. 
 
3.5.2 Exclusion Criteria 
Patients with any of the following characteristics were excluded from the study: 
 Did not give consent to participate in the study; 
 Did not have HER-2 positive breast cancer; 
 Was less than 18 years of age or greater than 80 years of age; 
 Was not receiving chemotherapy/HER-2 directed therapy; 
 Did not have a scheduled office appointment between August and October 2018: 
and 
 Was considered too sick by clinic staff to participate in the study. 
 
IRB procedures 
The study was conducted in accordance with the guidelines set forth by The 
University of Texas Institutional Review Board (IRB). The study application (2017-10-
0024) was approved by UT Austin IRB. 
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3.6 Data Analysis 
All data analyses were conducted using SAS 9.4 software. Descriptive statistics 
were conducted for independent and dependent variables as well as covariates. The a priori 
base alpha level for all inferential analyses to be conducted was set at 0.05, with a power 
of 0.80. T tests and analysis of variance (ANOVA) were conducted to assess mean 
differences for independent and dependent variables as well as covariates, while the chi 
square test/fisher’s exact test were used to assess associations between categorical 
variables. Multiple linear regression was used to predict the effect of the independent 
variables on the dependent variables, controlling for covariates. 
The regression equations are as follows: 
Y1 = B0 +B1X1 + B2 X2 +B3X3 +B4X4 + B5X5 + B6X6 + B7X7 +B8X8 + B9X9 + B10X10 + 
B11X11 + B12X12 + B13X13 +B14 (X1X2) + ei 
Y2 = B0 +B1X1 + B2 X2 +B3X3 +B4X4 + B5X5 + B6X6 + B7X7 +B8X8 + B9X9 + B10X10 + 
B11X11 + B12X12 + B13X13 +B14 (X1X2) + ei 
Y3 = B0 +B1X1 + B2 X2 +B3X3 +B4X4 + B5X5 + B6X6 + B7X7 +B8X8 + B9X9 + B10X10 + 
B11X11 + B12X12 + B13X13 +B14 (X1X2) + ei 
 
Y1= Cancer health related quality of life 
Y2 = Number of cancer-related emergency department visits 
Y3 = Number of cancer-related hospitalizations 
B0 = Intercept 
X1 = Cancer health literacy 
X2 = Patient activation 
X3 = Age 
X4 = Gender 
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X5 = Educational level 
X6 = Ethnicity 
X7 = Household income 
X8 = Insurance status 
X9 = Marital status 
X10 = Stage of breast cancer at diagnosis 
X11 = Time since diagnosis  
X12 = Type of breast cancer treatment received  
X13 = Comorbidities 
ei = Error term 
B1-14 are the regression coefficients for the respective predictor variables. 
 
Statistical Assumptions 
The multiple regression assumptions of normality, linearity, and homoscedasticity 
were tested for continuous and interval-level variables before running further analysis. 
Normality was assessed by examining the peakedness (kurtosis) and symmetry (skewness) 
of the distribution. Skewness refers to the degree to which a distribution is asymmetric 
while kurtosis addresses the degree to which a distribution deviates from the “peakedness” 
of a distribution. These were assessed using frequency histograms, residual scatterplots, 
probability plots, and statistical results provided via proc univariate. Skewness and kurtosis 
values greater than |2| and |7|, respectively, are a cause of concern for multivariate 
data.147,148 
The assumption of linearity is that a straight-line relationship exists between 
independent and dependent variables. This assumption was evaluated by assessing 
bivariate scatterplots of each interval-level independent variable and dependent variable. 
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A visual examination of the scatterplots was also performed to test the assumption that the 
variance of error was equal across all levels of the independent variables 
(homoscedasticity). Violations of the linearity and homoscedasticity assumptions do not 
compromise data analyses, but rather weakens them. Variable transformation may be 
warranted in cases of serious heteroscedasticity which occurs when the spread in standard 
deviations of residuals around predicted values is three times higher for the widest spread 
as for the most narrow spread.147 ANOVA and independent groups t-test have similar 
normality, linearity, and homoscedasticity assumptions. 
Multicollinearity is an additional problem often encountered in multiple regression 
analysis. It occurs when two predictor variables are highly correlated with one another, 
which if left undetected can prevent a predictor variable from reaching its statistical 
significance. Multicollinearity between independent variables was assessed in order to 
determine whether predictors were correlated among themselves. Presence of 
multicollinearity could greatly affect the results of a study by inflating the standard 
deviation of a regression weight and decreasing power. A rule of thumb to detect 
multicollinearity is a tolerance of less than 0.10 or a variance inflation factor (1 divided by 
tolerance) greater than 10 where tolerance = 1 – R2. R2 represents the proportion of variance 
in the first variable shared with the second variable. If significant collinearity exists 
between variables, only one variable is utilized in the regression analyses.147 
The chi square test assumptions of independence and percentage of expected cell 
counts were also assessed prior to running any analysis. Fisher’s exact test was used in 
instances where more than 20 percent of the expected cell counts were less than five.149 
Table 3.2 contains the measurement level for each variable, while table 3.3 contains a 
summary of the study objectives, hypotheses, and corresponding statistical tests. 
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Table 3.2: Study Variables, Measurement Level, and Statistical Tests 
Study variable Measurement level Statistical test 
Independent variable 
Descriptive Statistics 
 Mean, standard deviation 
(SD), median, mode, 
skewness, and kurtosis for 
continuous/interval 
variables 
 
 Frequencies for ordinal 
and nominal variables 
Cancer health literacy level Ordinal 
General health literacy level Ordinal 
Patient activation score Interval 
Patient activation level Ordinal 
 
Dependent variables 
Cancer health-related quality 
of life 
Interval 
Number of cancer-related 
emergency department visits 
Interval 
Number of cancer-related 
hospitalizations 
Interval 
Quality of patient-provider 
communication 
Interval 
 
Covariates 
Age Interval 
Gender Nominal 
Educational level Ordinal 
Ethnicity Nominal 
Household income Ordinal 
Insurance status Nominal 
Marital status Nominal 
Stage of breast cancer at 
diagnosis 
Ordinal 
Time since diagnosis Ordinal 
Type of breast cancer 
treatment received  
Nominal 
Comorbidities  Nominal 
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Table 3.3: Study Objectives, Hypotheses, and Corresponding Statistical Tests 
Objectives/Hypotheses Dependent Variables Independent Variables  Statistical Test 
Objective 1: To describe cancer health literacy, patient activation, clinical 
(stage of breast cancer at diagnosis, time since diagnosis, type of breast cancer 
treatment received, comorbidities) and demographic (age, gender, educational 
level, ethnicity, household income, insurance status, marital status) 
characteristics of a of breast cancer patient sample. 
Mean, Standard 
deviation (SD), 
Frequency 
Objective 2: To examine the relationship between health literacy and clinical and demographic 
characteristics in a sample of breast cancer patients. 
 
Cancer health 
literacy 
General health 
literacy 
Age T-test 
Gender 
Chi-square test 
Educational level 
Ethnicity 
Household income 
Insurance status 
Marital status 
Stage of breast cancer 
at diagnosis 
Time since diagnosis 
Type of breast cancer 
treatment received  
Comorbidities 
 
Objective 3:  To examine the relationship between patient activation and clinical and demographic 
characteristics in a sample of breast cancer patients.  
 Patient activation 
Age Correlation 
Gender 
ANOVA  
Educational level 
Ethnicity 
Household income 
Insurance status 
Marital status 
Stage of breast cancer 
at diagnosis 
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Time since diagnosis 
Type of breast cancer 
treatment received  
Comorbidities  
 
Objective 4:  To assess the relationship between cancer health literacy and patient activation in a 
sample of breast cancer patients. 
H1: Breast cancer patients who 
have adequate cancer health 
literacy will have higher patient 
activation compared to those 
that have limited cancer health 
literacy. 
Cancer health 
literacy Patient activation T-test 
 
Objective 5: To examine the relationship between cancer health literacy and patient-provider 
communication in a sample of breast cancer patients. 
H2: Breast cancer patients who 
have adequate cancer health 
literacy will have easier patient-
provider communication and 
understanding of information 
provided compared to those that 
have limited cancer health 
literacy. 
Cancer health 
literacy 
Quality of patient-
provider 
communication  
T test 
 
Objective 6: To examine the relationship between cancer health literacy and general health literacy 
in a sample of breast cancer patients. 
H3: There will be a significant 
positive relationship between 
cancer health literacy and 
general health literacy in the 
sample of breast cancer patient 
Cancer health 
literacy  
General health literacy Chi-square test 
 
 
Objective 7:  To determine the overall predictive validity of the health literacy skills (HLS) 
framework in explaining health outcomes (cancer health-related quality of life, cancer-related 
emergency department visits, and cancer-related hospitalizations) using cancer health literacy and 
patient activation, controlling for cancer health literacy X patient activation interaction and 
clinical/demographic characteristics. 
Table 3.3: Study Objectives, Hypotheses, and Corresponding Statistical Tests Contd. 
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H4: Cancer health literacy and 
patient activation will explain 
a significant amount of 
variance in cancer health-
related quality of life 
controlling for the interaction 
between cancer health literacy 
and patient activation as well 
as clinical and demographic 
characteristics 
Cancer HRQoL 
Cancer health literacy 
Patient activation 
Clinical and demo-
graphic covariates 
 
Multiple linear 
regression: 
R2; F test 
H5: Cancer health literacy and 
patient activation will explain 
a significant amount of 
variance in cancer-related 
emergency department visits 
controlling for the interaction 
between cancer health literacy 
and patient activation as well 
as clinical and demographic 
characteristics 
Number of cancer-
related emergency 
department visits 
H6: Cancer health literacy and 
patient activation will explain 
a significant amount of 
variance in cancer-related 
hospitalizations controlling for 
the interaction between cancer 
health literacy and patient 
activation as well as clinical 
and demographic 
characteristics 
Number of cancer-
related 
hospitalizations 
 
Objective 8:  To predict health-related quality of life in breast cancer patients using cancer health 
literacy and patient activation controlling for the interaction between cancer health literacy and 
patient activation as well as clinical and demographic characteristics 
H7:   Cancer health literacy 
and patient activation will be 
significant positive predictors 
of cancer health-related 
quality of life controlling for 
Cancer HRQoL 
Cancer health literacy  
Patient activation 
Multiple linear 
regression: 
R2; F test 
Table 3.3: Study Objectives, Hypotheses, and Corresponding Statistical Tests Contd. 
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the interaction between cancer 
health literacy and patient 
activation as well as clinical 
and demographic variables. 
Clinical and demo-
graphic covariates 
 
Objective 9:  To predict cancer-related emergency department visits in breast cancer patients using 
cancer health literacy and patient activation controlling for the interaction between cancer health 
literacy and patient activation as well as clinical and demographic variables.  
H8:   Cancer health literacy 
and patient activation will be 
significant negative predictors 
of cancer-related emergency 
department visits controlling 
for the interaction between 
cancer health literacy and 
patient activation as well as 
clinical and demographic 
variables. 
Number of cancer-
related emergency 
department visits 
Cancer health literacy  
Patient activation 
Clinical and demo-
graphic covariates 
Multiple linear 
regression: 
R2; F test 
 
Objective 10:  To predict cancer-related hospitalizations in breast cancer patients using cancer 
health literacy and patient activation controlling for the interaction between cancer health literacy 
and patient activation as well as clinical and demographic variables. 
H9:  Cancer health literacy 
and patient activation will be 
significant negative predictors 
of cancer-related 
hospitalizations controlling for 
the interaction between cancer 
health literacy and patient 
activation as well as clinical 
and demographic variables. 
Number of cancer-
related 
hospitalizations 
Cancer health literacy  
Patient activation 
Clinical and demo-
graphic covariates 
Multiple linear 
regression: 
R2; F test 
Table 3.3: Study Objectives, Hypotheses, and Corresponding Statistical Tests Contd. 
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3.7 Study Timeline 
The study was conducted over a period of seven months. Patients were continuously 
enrolled from August to October 2018. Patients were asked to fill out the survey while 
waiting to see the physician/healthcare provider during office visits. Analysis of the survey 
responses were conducted after the target number of patients had completed the survey. 
Table 3.4 contains the details of the study timeline. 
 
Table 3.4: Study Timeline 
Activity name Start date End date Duration 
A
ug
 2
01
8 
Se
pt
 2
01
8 
O
ct
 2
01
8 
N
ov
 2
01
8 
D
ec
 2
01
8 
Ja
n 
20
19
 
Fe
b 
20
19
 
Project duration 08/18 2/18 7 months             
Obtain consent 
and administer 
survey 
08/18 10/18 3 months        
Data analysis 
and write-up 
11/18 2/19 4 months        
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Chapter 4: Results 
The main findings of the study are discussed in this chapter. First, results from the 
pretest form are discussed followed by details of the data preparation process and 
preliminary data analysis results. Next, the demographics of study participants are 
described. Finally, the results of bivariate and multivariate analyses conducted to test study 
hypotheses are presented in detail. 
 
4.1 Pretest Results 
Three breast cancer patients who met the study’s inclusion/exclusion criteria 
evaluated the study survey upon completion using a survey evaluation form (Appendix 5). 
The evaluation form consisted of questions to assess the survey based on the readability of 
survey items, relevance of survey items, survey format, and time required to complete the 
survey.  
The three respondents completed the survey within 10 minutes. With regards to 
readability, the three patients stated that all survey items were clear and easy to understand. 
They also concurred that all survey items were relevant to the research and two agreed that 
there were no missing issues of importance. However, one patient suggested that questions 
regarding diet should have been included in the study stating that “what you eat is very 
important…when fighting cancer or inflammation.” Finally, all three patients found the 
survey format user friendly and easy to follow.  
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4.2 Data Preparation and Cleaning 
One hundred and sixty-four patients who met the study’s inclusion/exclusion 
criteria were approached by clinical staff in 12 Texas Oncology clinics and offered 
participation in the study. The response rate was high (90%) as 147 patients gave their 
consent to participate and completed the survey. However, the responses of one patient 
were excluded because she had not yet begun treatment, leading to a final study sample 
size of 146. Table 4.1 and Figure 4.1 contain details of study participation by clinic.  
 
Table 4.1 Study Participation by Clinic 
S/N Site Name Completed Declined Total 
1 Austin Central 4 1 5 
2 Austin Midtown 7 0 7 
3 Austin Round Rock 15 3 18 
4 Austin South 3 2 5 
5 Dallas Presbyterian 34 0 34 
6 El Paso Grandview 5 0 5 
7 Mesquite   11* 0 11 
8 Rockwall 15 0 15 
9 San Antonio Downtown 5 6 11 
10 San Antonio NE 16 3 19 
11 San Antonio SO 10 0 10 
12 Tyler 22 2 24 
147 17 164 
*patient responses were excluded from study because patient did not meet inclusion/exclusion criteria 
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Figure 4.1 Map of Texas Showing Location of Participating Clinics 
 
Responses to the 6 items on the cancer health literacy tool (CHLT-6) were used to 
generate probabilities of adequate and limited cancer health literacy using the CHLT-6 
algorithm. The responses of patients to the 6 items of the Newest Vital Scale were scored 
as right (1) or wrong (0) and summed up. Patients were considered to either have limited 
general health literacy (total score less than 4) or adequate literacy (total score 4 to 6) based 
on their total NVS score. The responses of patients to the 13 items of the Patient Activation 
Measure (PAM-13) were also converted to a PAM score on the 0 – 100 scale, using the 
PAM-13 score spreadsheet. The generated health literacy and PAM scores were then used 
in subsequent analyses.  
 = Cities where participating clinics were located 
https://www.worldatlas.com/webimage/countrys/namerica/usstates/cities/txmjcity.htm 
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For the covariates, gender was excluded from bivariate and multivariate analysis 
because 99.3 percent of the study sample was female. The education variable was 
dichotomized into low formal education (patients with less than high school education and 
high school graduate/GED) and high formal education (patients with college and post 
graduate degrees). Also, a majority of patients received multiple types of treatment and had 
multiple comorbidities so patient responses to these items were summed up to get a 
composite score for the number of treatment types received as well as the number of 
comorbidities, respectively. The responses of the study participants were compiled in a 
single Excel spreadsheet that was subsequently uploaded into SAS 9.4 (SAS Institute, 
Cary, N.C.) for data preparation, screening, and analysis. Data were then assessed for 
normality, outliers and extent of missing data. 
 
4.3 Preliminary Data Analysis 
The normality of interval level variables was assessed by measuring the symmetry 
and kurtosis of each variable’s distribution. None of the interval level variables were 
problematic as their values fell within the threshold for skewness (l2l) and kurtosis (l7l). 
See Table 4.2. Potential outliers were screened for by inspecting z-scores of continuous, 
interval variables. No outliers were identified in the data. Thirty-one instances of missing 
data were observed across nine demographic/clinical survey items and the two 
communication items. One patient had no entry for the number of ED visits and 
hospitalizations items. Patients were not required to have a comorbidity so blank entries 
for this item were not considered missing data. For the CHLT-6, NVS, PAM-13, and 
FACT-G items, recommended techniques were employed to generate scores for partially 
completed scale items.18,133,139,145,146 For FACT-G missing items, subscale scores were 
prorated by multiplying the sum of the subscale by the number of items in the subscale, 
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then dividing by the number of items actually answered. For PAM scores missing items 
were designated N/A and for the health literacy items (CHLT-6 and NVS), unanswered 
questions were scored as 0. Two individuals had no entries at all for the Newest Vital Sign 
items.  
 
Table 4.2 Skewness and Kurtosis Values of Interval Level Variables 
Variable Skewness Kurtosis 
Age -0.13 -0.64 
PAM scores 0.53 -0.45 
Patient communicating breast cancer 
concerns to health care provider 
-1.91 3.05 
Patient understanding of information 
given by healthcare providers 
-0.96 0.28 
Number of treatment types received -0.17 -0.79 
Number of comorbidities 1.05 0.63 
 
Furthermore, the assumptions of normality, homoscedasticity, linearity, 
independence, and multicollinearity of the quality of life dependent variable (overall 
FACT-G score) were checked prior to multivariate statistical analyses. The distributions of 
the residuals were found to be normal based on histograms of the residuals and normal 
probability plots. The assumption of homoscedasticity was also assessed by examining a 
scatterplot of the residuals against the predicted values. Even though there was some 
heteroscedasticity, Ordinary Least Square (OLS) regression is robust to minor violations 
of this assumption. Based on the non-curved shape of the residual scatter plots, the 
assumption of linearity of residuals was met. Since participants responded individually to 
the survey, the assumption of independence was met. Finally, multicollinearity was tested 
by performing collinearity diagnostics and assessing the tolerance and variance inflation 
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factor between each pair of independent variables. None of the tolerance values were less 
than 0.1, and none of the variation factors were greater than 10. Therefore, multicollinearity 
was not considered a problem and all demographic/clinical variables were eligible to be 
used in the multiple regression analysis.  
After checking for multicollinearity and violations of assumptions, no rescoring or 
transformation of the data was deemed necessary. The quality of life variable did not have 
violations of skewness and kurtosis, and its distribution was approximately normal. Upon 
completion of preliminary data analysis, descriptive, bivariate and multivariate analyses 
were conducted to achieve the study objectives and test study hypotheses. These analyses 
and their results are outlined in detail below. 
 
4.4 Descriptive Statistics Results 
The demographic and clinical characteristics of the study participants are described 
in this section and details are listed in Table 4.3. The average age of study participants was 
57.1±10.8 years. The majority were female (99.3%), Caucasian (71.7%), married or in a 
relationship (69.5%), had a high formal education level (52.8%), had private insurance 
(59.7%), and had an annual household income over $50,000 (66.2%). Clinically, patients 
were widely distributed across the four stages of breast cancer (stage 1 to stage 4), and 
most patients had been diagnosed for the first time within the last 5 years (78.0%). The 
majority (79.4%) of patients had two comorbidities or less with hypertension (27.6%) 
being the most common comorbidity. 
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Table 4.3 Demographic and Clinical Characteristics of Study Participants 
Variable Mean (SD) 
Age (n = 141) 57.1 (10.8) 
 Frequency (%)* 
Gender (n = 145) 
Male 1 (0.7) 
Female 144 (99.3) 
Race (n = 145) 
African-American or non-Hispanic black  12 (8.3) 
Asian-American or Pacific Islander 5 (3.5) 
Caucasian or non-Hispanic white 104 (71.7) 
Mexican-American or Hispanic 18 (12.4) 
Other† 6 (4.1) 
Educational level (n = 144) 
Low formal education 68 (47.2) 
High formal education  76 (52.8) 
Household income (n = 136) 
Less than $25,000 24 (17.6) 
$25,000 to $50,000 22 (16.2) 
> $50,000 to $75,000 33 (24.3) 
> $75,000 to $100,000 25 (18.4) 
> $100,000 32 (23.5) 
Insurance status (n = 144) 
Private insurance 86 (59.7) 
Medicare          21 (14.6) 
Medicaid                                                                          15 (10.4) 
Multiple 21 (14.6) 
Other† 1 (0.7) 
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Marital status (n = 144) 
Single, in a relationship                                         7 (4.9) 
Single, not in a relationship  17 (11.8) 
Married                 87 (60.4) 
Partner/Living together         6 (4.2) 
Divorced/Separated 18 (12.5) 
Widowed 9 (6.2) 
Stage of breast cancer at diagnosis (n = 144) 
Stage 0                                                             4 (2.8) 
Stage 1    33 (22.9) 
Stage 2                                                             32 (22.2) 
Stage 3 32 (22.2) 
Stage 4 35 (24.3) 
Do not know 8 (5.6) 
Time since breast cancer diagnosis (n = 144) 
1 year or less                  73 (50.4) 
More than 1 year but less than 5 years 40 (27.6) 
More than 5 years but less than 10 years 17 (11.7) 
More than 10 years 15 (10.3) 
Number of breast cancer treatment types received (n = 146) 
1 22 (15.1) 
2 31 (21.2) 
3 51 (34.9) 
4 37 (25.4) 
5 5 (3.4) 
Type of breast cancer treatment received (n = 146) 
Chemotherapy alone 22 (15.1) 
Chemotherapy + Radiation 2 (1.4) 
Chemotherapy + Surgery 21 (14.4) 
Table 4.3 Demographic and Clinical Characteristics of Study Participants Contd. 
 88 
Chemotherapy + Hormone 7 (4.8) 
Chemotherapy + Herceptin 1 (0.7) 
Multiple 93 (63.7) 
Number of comorbidities (n = 146) 
0 39 (26.7) 
1 42 (28.8) 
2 34 (23.3) 
3 17 (11.6) 
4 10 (6.8) 
5 3 (2.1) 
6 1 (0.7) 
Comorbidity type (n = 146)* 
Hypertension        40 (27.6) 
High cholesterol 29 (20.0) 
Arthritis 26 (17.9) 
Depression 25 (17.2) 
Thyroid problems 25 (17.2) 
Anxiety 24 (16.6) 
Diabetes 19 (13.1) 
Asthma 13 (9.0) 
Heart disease 6 (4.1) 
Kidney problems 2 (1.4) 
Osteoporosis 2 (1.4) 
Other† 9 (6.2) 
*Sum of percentage values is not equal to 100% because some patients reported multiple categories or none 
†“Other” category for insurance and comorbidity type was not specified; For race, “other” category consisted of mixed 
race or not specified. 
 
 
Table 4.3 Demographic and Clinical Characteristics of Study Participants Contd. 
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For the independent variables, 92 percent (N=134) of participants had adequate 
cancer health literacy while 79 percent (N=114) had adequate general health literacy based 
on their CHLT-6 and NVS scores, respectively. The reliability of the general health literacy 
instrument (NVS) was evaluated using Cronbach's coefficient alpha. The NVS had 
moderate internal consistency (alpha=0.67). The mean patient activation score was 
65.9±15.7 (range 34.2 to 100.0) with most patients (68%, N=99) in the higher levels (level 
3 or 4) of activation (Table 4.4). The Cronbach's coefficient alpha of the PAM was 0.88 
which indicated a high internal consistency.  
 
Table 4.4 Patient Activation Level Distribution (N=146) 
Patient activation level (n = 146) Frequency (%) 
Level 1 16 (11.0) 
Level 2 31 (21.2) 
Level 3 46 (31.5) 
Level 4 53 (36.3) 
 
With regards to the dependent variables, the average quality of life based on FACT-
G scores was 82.6±16.1 (range 36.0 to 108.0) with emotional well-being having the highest 
domain average (19.6 out of 24.0)) and functional well-being having the lowest domain 
average (20.1 out of 28.0) (Table 4.5). The Cronbach's coefficient alpha of the overall 
FACT-G score was 0.92 which indicated a high internal consistency. The internal 
consistency was also generally high for the four FACT-G domains.  
 
 
 90 
Table 4.5 FACT-G Scores 
FACT-G domain Mean (SD) Range Reliability 
Physical well-being 20.3 (6.2) 2.0 - 28.0 0.89 
Social well-being 22.6 (5.3) 2.0 - 28.0 0.88 
Emotional well-being 19.6 (3.4) 8.4 - 24.0 0.68 
Functional well-being 20.1 (5.7) 4.0 - 28.0 0.85 
Overall FACT-G 82.6 (16.1) 36.0 - 108.0 0.92 
 
The majority of patients found it somewhat or extremely easy (90.2%, N= 128) to 
communicate their breast cancer concerns to their healthcare provider and somewhat or 
extremely easy (83.5%, N= 121) to understand information given by healthcare providers 
about breast cancer and its management (Table 4.6).  
Only five patients (3.4%) reported an ED visit and two patients (1.4%) reported a 
hospitalization in the last 30 days due to a breast cancer complication. 
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Table 4.6 Communication Difficulty Frequency Distribution and Means 
 
Communication 
Difficulty  
 
Frequency (%) 
Mean 
(SD) Extremely 
difficult 
Somewhat 
difficult 
Neither 
easy nor 
difficult 
Somewhat 
easy 
Extremely 
easy 
Difficulty of 
communicating breast 
cancer concerns to 
healthcare provider 
(N=142) 
0 (0.0) 4 (2.8) 10 (7.0) 25 (17.6) 103 (72.6) 4.6 (0.7) 
Difficulty of 
understanding 
information given by 
healthcare providers 
about breast cancer 
and its management 
(N=145) 
0 (0.0) 6 (4.1) 18 (12.4) 53 (36.6) 68 (46.9) 4.3 (0.8) 
 
4.5 Bivariate Analysis Results 
Bivariate data analyses were conducted using t-tests, correlations, ANOVA, and 
fisher’s exact tests to assess relationships between variables and test study hypotheses as 
outlined below: 
4.5.1 To examine the relationships between cancer health literacy and 
clinical/demographic characteristics in a sample of breast cancer patients. Ninety-
two percent of study participants (N=134) had adequate cancer health literacy while 
eight percent (N=12) had limited cancer health literacy. 
Results in Table 4.7 show that there were no significant relationships between cancer health 
literacy and most clinical/demographic variables except for household income (X2=12.84; 
df=4; p=0.0198) and education (X2=6.85; df=1; 0.0132). Most patients with adequate 
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cancer health literacy earned over $50,000 (68.0%, N= 85) and were highly educated (at 
least had a college degree), while many patients with limited cancer health literacy earned 
less than $25,000 (54.5%, N= 6) and had low formal education (had high school 
education/GED or less). 
 
Table 4.7 Relationships between Cancer Health Literacy and Clinical/Demographic 
Variables 
Variable 
Limited 
Cancer 
Health 
Literacy 
Adequate 
Cancer 
Health 
Literacy T test p value 
 N Mean (SD) 
Age 
11 
57.2 (10.0) 
130 
57.1 (10.9) 
 
0.04 
 
0.9702 
Number of comorbidities 12 1.6 (1.8) 
134 
1.5 (1.3) 
 
0.17 
 
0.8672 
Number of treatments received  12 2.6 (1.0) 
134 
2.8 (1.1) 
 
0.75 
 
0.4554 
 Frequency (%) X2 p value 
Race (n = 145) 
African-American or non-Hispanic black 2 (16.7) 10 (7.5) 
7.58 0.1122 
Asian-American or Pacific Islander 0 (0.0) 5 (3.8) 
Caucasian or non-Hispanic white 6 (50.0) 98 (73.7) 
Mexican-American or Hispanic 4 (33.3) 14 (10.5) 
Other 0 (0.0) 6 (4.5) 
Educational level (n = 144) 
Low formal education 10 (83.3) 58 (43.9) 
6.85 0.0132 
High formal education  2 (16.7) 74 (56.1) 
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Household income (n = 136)  
Less than $25,000 6 (54.5) 18 (14.4) 
12.84  0.0198 
$25,000 to $50,000 0 (0.0) 22 (17.6) 
> $50,000 to $75,000 3 (27.3) 30 (24.0) 
> $75,000 to $100,000 1 (9.1) 24 (19.2) 
> $100,000 1 (9.1) 31 (24.8) 
Insurance status (n = 144) 
Private insurance 5 (41.7) 81 (61.4) 
4.80 0.2067 
Medicare          3(25.0) 18 (13.6) 
Medicaid                                                                         3 (25.0) 12 (9.1) 
Multiple 1 (8.3) 20 (15.1) 
Other 0 (0.0) 1 (0.8) 
Marital status (n = 144) 
Single, in a relationship                                        0 (0.0) 7 (5.3) 
8.32 0.0871 
Single, not in a relationship  3 (27.3) 14 (10.5) 
Married                 5 (45.4) 82 (61.6) 
Partner/Living together         1 (9.1) 5 (3.8) 
Divorced/Separated 0 (0.0) 18 (13.5) 
Widowed 2 (18.2) 7 (5.3) 
Stage of breast cancer at diagnosis (n = 144) 
Stage 0                                                            1 (8.3) 3 (2.3) 
5.81 0.2476 
Stage 1    1 (8.3) 32 (24.2) 
Stage 2                                                            2 (16.7) 30 (22.7) 
Stage 3 3 (25.0) 29 (22.0) 
Stage 4 3 (25.0) 32 (24.2) 
Do not know 2 (16.7) 6 (4.6) 
Table 4.7 Relationships between Cancer Health Literacy and Clinical/Demographic 
Variables Contd. 
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Table 4.7 Relationships between Cancer Health Literacy and Clinical/Demographic 
Variables Contd. 
Time since breast cancer diagnosis (n = 145) 
1 year or less                  5 (41.7) 68 (51.1) 
2.76 0.4580 
More than 1 year but less than 5 years 5 (41.7) 35 (26.3) 
More than 5 years but less than 10 years 2 (16.6) 15 (11.3) 
More than 10 years 0 (0.0) 15 (11.3) 
T-tests conducted for interval variables (age, number of comorbidities, number of treatment types received). Fisher’s 
exact test conducted for other variables. 
 
4.5.2 To examine the relationships between general health literacy and 
clinical/demographic characteristics in a sample of breast cancer patients. Seventy-
nine percent of study participants (N=114) had adequate general health literacy 
while twenty-one percent had limited general health literacy (N=30).   
Results in Table 4.8 show that there were no significant relationships between general 
health literacy and most clinical/demographic variables except for age (t=2.28; df=137; 
p=0.0244), education (X2=4.14; df=1; p=0.0419) and insurance (X2=9.3; df=4; p=0.0441). 
Patients with adequate general health literacy were significantly younger (56.0±10.8 years) 
than patients with limited general health literacy (61.2±9.9 years). Patients with adequate 
general health literacy also tended to have a high level of formal educational (57.5%, 
N=65) while those with limited general health literacy tended to have low formal education 
(63.3%, N= 19). In addition, more than half of patients with adequate general health 
literacy had private insurance alone (65.2%, N= 73), while a third of patients with limited 
general health literacy had Medicare or Medicaid only (33.3%, N=10). 
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Table 4.8 Relationships between General Health Literacy and Clinical/Demographic 
Variables 
Variable 
Limited 
General 
Health 
Literacy 
Adequate 
General 
Health 
Literacy T test p value 
 N Mean (SD) 
Age 
27 
61.1 (9.7) 
112 
56.0 (10.8) 
 
2.28 
 
0.0244 
Number of comorbidities 30 1.5 (1.6) 
114 
1.5 (1.3) 
 
0.03 
 
0.9747 
Number of treatments received 30 2.6 (0.9) 
114 
2.9 (1.1) 
 
1.32 
 
0.1902 
 Frequency (%) X2 p value 
Race (n = 143) 
African-American or non-Hispanic black  5 (16.7) 7 (6.2) 
4.48 0.2578 
Asian-American or Pacific Islander 1 (3.3) 4 (3.5) 
Caucasian or non-Hispanic white 18 (60.0) 85 (75.2) 
Mexican-American or Hispanic 4 (13.3) 13 (11.5) 
Other 2 (6.7) 4 (3.6) 
Educational level (n = 143) 
Low formal education 19 (63.3) 48 (42.5) 
4.14 0.0419 
High formal education 11 (36.7) 65 (57.5) 
Household income (n = 134) 
Less than $25,000 7 (28.0) 17 (15.6) 
2.54 0.6675 
$25,000 to $50,000 4 (16.0) 18 (16.5) 
> $50,000 to $75,000 6 (24.0) 26 (23.8) 
> $75,000 to $100,000 4 (16.0) 21 (19.3) 
> $100,000 4 (16.0) 27 (24.8) 
 96 
Insurance status (n = 142) 
Private insurance 12 (40.0) 73 (65.2) 
9.34 0.0441 
Medicare          6 (20.0) 14 (12.5) 
Medicaid                                                                         4 (13.3) 11 (9.8) 
Multiple 7 (23.4) 14 (12.5) 
Other 1 (3.3) 0 (0.0) 
Marital status (n = 142) 
Single, in a relationship                                        1 (3.5) 6 (5.3) 
4.19 0.4460 
Single, not in a relationship  5 (17.2) 12 (10.6) 
Married                 16 (55.2) 70 (62.0) 
Partner/Living together         2 (6.9) 4 (3.5) 
Divorced/Separated 2 (6.9) 16 (14.2) 
Widowed 3 (10.3) 5 (4.4) 
Stage of breast cancer at diagnosis (n = 142) 
Stage 0                                                            1 (3.3) 3 (2.7) 
9.55 0.1220 
Stage 1    5 (16.7) 28 (25.0) 
Stage 2                                                            5 (16.7) 26 (23.2) 
Stage 3 6 (20.00) 25 (22.3) 
Stage 4 8 (26.6) 27 (24.1) 
Do not know 5 (16.7) 3 (2.7) 
Time since breast cancer diagnosis (n = 143) 
1 year or less                  12 (40.0) 60 (53.1) 
2.06 0.5322 
More than 1 year but less than 5 years 10 (33.3) 29 (25.7) 
More than 5 years but less than 10 years 5 (16.7) 12 (10.6) 
More than 10 years 3 (10.0) 12 (10.6) 
T-tests conducted for interval variables (age, number of comorbidities, number of treatment types received). Chi-square 
test conducted for education variable. Fisher’s exact test conducted for other variables. 
 
Table 4.8 Relationships between General Health Literacy and Clinical/Demographic 
Variables Contd. 
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4.5.3 To examine the relationships between patient activation score and 
clinical/demographic characteristics in a sample of breast cancer patients. The mean 
patient activation score was 65.9±15.7 (range 34.2 to 100.0) with most patients 
(68%, N=99) in the higher levels (level 3 or 4) of activation 
Results in Table 4.9 showed no statistically significant differences in patient activation 
scores across most clinical/demographic variables except for race. A Tukey’s post-hoc test 
showed that the mean patient activation score for Caucasians (68.9±16.0) was significantly 
higher than that for Blacks (54.5±6.9) and Hispanics (58.3±10.7) at an alpha level of p < 
0.05.  
 
Table 4.9 Relationships between Patient Activation and Clinical/Demographic 
Variables 
Variable Correlation p value 
Age (n=141) 0.11 0.1872 
Number of comorbidities (n=146) 0.06 0.4644 
Number of treatments received (n=146) 0.06 0.4727 
 Mean Patient Activation Score (SD) F value p value 
Race (n = 145) 
African-American or non-Hispanic black  54.5 (6.9) 
4.01 0.0041 
Asian-American or Pacific Islander 62.2 (23.4) 
Caucasian or non-Hispanic white 68.9 (16.1) 
Mexican-American or Hispanic 58.3 (10.7) 
Other 65.0 (10.0) 
Educational level (n = 144) 
Low formal education 64.3 (15.9) 
1.24 0.2683 
High formal education  67.2 (15.3) 
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Table 4.9 Relationships between Patient Activation and Clinical/Demographic Variables 
Contd. 
Household income (n = 136) 
Less than $25,000 63.9 (15.8) 
0.56 0.6915 
$25,000 to $50,000 66.2 (16.9) 
> $50,000 to $75,000 68.3 (15.8) 
> $75,000 to $100,000 63.8 (16.4) 
> $100,000 68.5 (14.9) 
Insurance status (n = 144) 
Private insurance 66.2 (16.0) 
0.20 0.8966 
Medicare          67.1 (18.1) 
Medicaid                                                                         64.1 (11.1) 
Multiple 64.7 (15.6) 
Other 58.1 (0.00) 
Marital status (n = 144) 
Single, in a relationship                                        65.5 (18.5) 
1.74 0.1668 
Single, not in a relationship  62.8 (12.5) 
Married                 67.0 (16.6) 
Partner/Living together         68.0 (13.1) 
Divorced/Separated 60.2 (13.5) 
Widowed 75.0 (12.2) 
Stage of breast cancer at diagnosis (n = 144) 
Stage 0                                                            55.4 (10.2) 
2.27 0.0797 
Stage 1    65.9 (15.2) 
Stage 2                                                            66.7 (15.3) 
Stage 3 65.6 (17.1) 
Stage 4 69.0 (16.6) 
Do not know 57.0 (8.9) 
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Table 4.9 Relationships between Patient Activation and Clinical/Demographic Variables 
Contd. 
Time since breast cancer diagnosis (n = 145) 
1 year or less                  65.6 (15.0) 
0.16 0.9212 
More than 1 year but less than 5 years 66.4 (14.5) 
More than 5 years but less than 10 years 68.5 (19.0) 
More than 10 years 64.3 (18.8) 
Pearson’s correlation conducted for interval variables (age, number of comorbidities, number of treatment types 
received). ANOVA conducted for other variables. 
 
4.5.4 To assess the relationship between cancer health literacy and patient activation in a 
sample of breast cancer patients. 
H1: Breast cancer patients who have adequate cancer health literacy will have 
a higher patient activation score compared to those that have limited cancer 
health literacy. 
An independent groups t-test showed no significant difference in mean patient activation 
score between patients with limited cancer health literacy (63.7±10.4) and those with 
adequate cancer health literacy (66.1±16.1) (t=0.50; df=144; p=0.62). Therefore, 
hypothesis H1 was not supported. 
 
4.5.4 To examine the relationship between cancer health literacy and patient-provider 
communication in a sample of breast cancer patients. 
H2: Breast cancer patients who have adequate cancer health literacy will have 
easier patient-provider communication and understanding of information 
provided compared to those that have limited cancer health literacy. 
An independent groups t-test showed no significant difference in the ease of 
communicating breast cancer concerns to a healthcare provider between patients with 
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limited cancer health literacy (4.5±0.7) and patients with adequate cancer health literacy 
(4.6±0.7) (t=0.43; df=140; p=0.67). Also, there was no significant difference in the ease of 
understanding information given by healthcare providers about breast cancer and its 
management between patients with limited cancer health literacy (3.7±1.2) and patients 
with adequate cancer health literacy (4.3±0.8) (t =1.91; df =11.9; p=0.08). Therefore, 
hypothesis H2 was not supported in terms of communication and understanding. Tables 
4.10 and 4.11 show the distribution of patient responses to the communication and 
understanding items by cancer health literacy level. 
 
Table 4.10 Relationship between Communicating Breast Cancer Concerns to 
Healthcare Provider and Cancer Health Literacy Level (N=142) 
Difficulty of 
communicating 
breast cancer 
concerns to 
healthcare 
provider  
Frequency (%) 
 
 
Mean 
(SD) 
 
T test 
 
p value Extremely 
difficult 
Somewhat 
difficult 
Neither 
easy 
nor 
difficult 
Somewhat 
easy 
Extremely 
easy 
Limited cancer 
health literacy 
0 (0.0) 0 (0.0) 1 (10.0) 3 (30.0) 6 (60.0) 4.5 (0.7) 
0.43 0. 6655 
Adequate 
cancer health 
literacy 
0 (0.0) 4 (3.0) 9 (6.8) 22 (16.7) 97 (73.5) 4.6 (0.7) 
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Table 4.11 Relationship between Patient Understanding of Information given by 
Healthcare Providers on Breast Cancer and Cancer Health Literacy Level (N=145) 
Difficulty of 
understanding 
information 
given by 
healthcare 
providers  
about breast 
cancer and its 
management 
Frequency (%) 
 
 
Mean 
(SD) 
 
T test 
 
p value Extremely 
difficult 
Somewhat 
difficult 
Neither 
easy nor 
difficult 
Somewhat 
easy 
Extremely 
easy 
Limited 
cancer health 
literacy 
0 (0.0) 2 (16.7) 4 (33.3) 2 (16.7) 4 (33.3) 3.7 (1.2) 
1.91 0.0807 
Adequate 
cancer health 
literacy 
0 (0.0) 4 (3.0) 14 (10.5) 51 (38.4) 64 (48.1) 4.3 (0.8) 
 
4.5.5 To assess the relationship between cancer health literacy and general health literacy 
in a sample of breast cancer patients. 
H3: There will be a positive relationship between cancer health literacy and 
general health literacy in the sample of breast cancer patients. 
A Chi square analysis revealed a significant relationship between cancer health literacy and 
general health literacy (X2= 8.21; df = 1; p = 0.0042). Most patients who had adequate 
cancer health literacy (82.0%, N=109) also had adequate general health literacy. See Table 
4.12. Therefore, hypothesis H3 was supported. 
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Table 4.12 Cancer Health Literacy vs General Health Literacy (N=144) 
 
Variable 
Frequency (%) 
X2 p value 
Limited 
Cancer 
Health 
Literacy 
Adequate 
Cancer 
Health 
Literacy 
Limited General Health 
Literacy 6 (54.5) 24 (18.0) 
8.21 0.0109 
Adequate General Health 
Literacy 
5 (45.5) 109 (82.0) 
 
4.6 Multivariate Analysis Results 
Multivariate data analyses were conducted using linear regression to assess 
relationships between variables and test other study hypotheses. Due to the low number of 
cancer-related ED visits (3.4%, N=5) and hospitalizations (1.4%, N=2) reported by study 
participants, multivariate analyses were not conducted on these two dependent variables. 
Bivariate analyses were completed on the quality of life dependent variable (overall 
FACT-G score) and independent variables to develop a parsimonious model (Table 4.13). 
All clinical/demographic factors that were not related to the quality of life dependent 
variable were excluded from the multivariate analyses. Eight of the ten 
clinical/demographic variables were dropped. The retained clinical/demographic factors 
were education and number of treatment types received.  
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Table 4.13 Relationships between Health-Related Quality of Life (Overall FACT-G 
Score) and Clinical/Demographic Variables 
Variable Correlation p value 
Age (n=141) 0.10 0.2236 
Number of comorbidities (n=146) 0.13 0.1157 
Number of treatment types received (n= 146) 0.21 0.0101 
 Mean FACT-G Score (SD) F value p value 
Race (n = 145) 
African-American or non-Hispanic black  76.0 (13.9) 
2.29 0.1048 
Asian-American or Pacific Islander 70.6 (12.3) 
Caucasian or non-Hispanic white 84.8 (16.0) 
Mexican-American or Hispanic 78.7 (18.7) 
Other 80.7 (9.0) 
Educational level (n = 144) 
Low formal education 79.2 (17.7) 
5.97 0.0158 
High formal education 85.7 (14.1) 
Household income (n = 136) 
Less than $25,000 78.3 (16.1) 
0.74 0.5656 
$25,000 to $50,000 83.6 (16.4) 
> $50,000 to $75,000 84.9 (14.4) 
> $75,000 to $100,000 83.2 (16.4) 
> $100,000 84.9 (17.7) 
Insurance status (n = 144) 
Private insurance 83.1 (16.4) 
0.32 0.8075 
Medicare          80.4 (13.7) 
Medicaid                                                                         80.0 (20.0) 
Multiple 83.9 (15.1) 
Other 79.0 (0.00) 
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Table 4.13 Relationships between Health-Related Quality of Life (Overall FACT-G 
Score) and Clinical/Demographic Variables Contd. 
Marital status (n = 144) 
Single, in a relationship                                        80.7 (19.7) 
0.36 0.8705 
Single, not in a relationship  80.9 (11.7) 
Married                 83.6 (16.8) 
Partner/Living together         85.1 (14.5) 
Divorced/Separated 79.3 (18.2) 
Widowed 85.7 (12.4) 
Stage of breast cancer at diagnosis (n = 144) 
Stage 0                                                            77.3 (26.0) 
0.41 0.8350 
Stage 1    81.1 (14.1) 
Stage 2                                                            84.6 (14.5) 
Stage 3 82.3 (16.7) 
Stage 4 84.0 (18.7) 
Do not know 77.8 (14.0) 
Time since breast cancer diagnosis (n = 145) 
1 year or less                  80.5 (16.5) 
1.34 0.2761 
More than 1 year but less than 5 years 86.0 (14.9) 
More than 5 years but less than 10 years 85.6 (12.4) 
More than 10 years 81.1 (20.6) 
Pearson’s correlation conducted for interval variables (age, number of comorbidities, number of treatment types 
received). ANOVA conducted for other variables. 
 
The following multivariate study objectives and corresponding hypotheses were 
tested. The interaction term of cancer health literacy X patient activation was subsequently 
excluded since bivariate analysis did not show any significant relationship between the two 
constructs. Details of the hypotheses test results is described below. A summary is 
presented in Table 4.13. 
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4.6.1: To determine the overall predictive validity of the health literacy skills (HLS) 
framework in explaining cancer health-related quality of life using cancer health 
literacy and patient activation, controlling for clinical and demographic 
characteristics. 
H4: Cancer health literacy and patient activation will explain a significant 
amount of variance in cancer health-related quality of life, controlling for 
clinical and demographic characteristics. 
The hypothesis that cancer health literacy and patient activation would predict a significant 
amount of variance in cancer health-related quality of life was supported by the data 
(F=10.31; df=4, 139; p<0.0001). This supports the overall predictive validity of the health 
literacy skills (HLS) framework in explaining health-related quality of life. Twenty three 
percent of the variation in health-related quality of life (R2=0.23) was accounted for by 
patient activation and two demographic/clinical characteristics (educational level and 
number of treatment types received), with an adjusted R2 of 21 percent (R2= 0.21). 
Therefore, hypothesis H4 was supported. 
Hypotheses H5 and H6 could not be tested because there were very few reported incidents 
of cancer-related ED visits and hospitalizations. The overall predictive validity of the HLS 
framework in explaining the variance in these two dependent variables was not assessed. 
 
4.6.2: To predict cancer health-related quality of life in breast cancer patients using cancer 
health literacy and patient activation controlling for clinical and demographic 
characteristics. 
H7: Cancer health literacy and patient activation will be significant positive 
predictors of cancer health-related quality of life controlling for clinical and 
demographic variables. 
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Multiple linear regression analysis showed no significant relationship between cancer 
health literacy and health-related quality of life (B = -1.31, p = 0.77) while controlling for 
covariates (education and number of treatment types received).  However, patient 
activation was positively related to health-related quality of life (B = 0.40, p < 0.0001) 
while controlling for education and number of treatment types received (Table 4.14). A 1-
point increase in patient activation score was associated with a 0.4-point increase in health-
related quality of life score. Therefore, hypothesis H7 was partially supported. 
Hypotheses H8 and H9 could also not be tested because there were very few reported 
incidents of cancer-related ED visits and hospitalizations. The ability of cancer health 
literacy and patient activation to predict these two dependent variables was not assessed. 
 
Table 4.14 Multiple Regression Analysis of Health Literacy Skills Framework (N=144) 
Variables 
Unstandardized 
Coefficients 
Standardized 
Coefficients 
95% 
Confidence 
Intervals p value 
B Std. Error Beta 
Lower 
bound 
Upper 
bound 
Intercept 46.77 7.00  32.93 60.60 <0.01 
Independent variables 
Cancer health literacy level -1.31 4.47 -0.02 -10.14 7.52 0.77 
Patient activation score 0.40 0.08 0.39 0.25 0.56 <0.01 
Covariates 
Educational level 5.04 2.48 0.16 0.14 9.95 0.04 
Number of treatment types 
received 2.75 1.12 0.18 0.53 4.97 0.02 
F statistic=10.31; df=4, 139; Model p-value<0.0001; R2=0.23; Adjusted R2=0.21 
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4.7 Summary of Study Findings 
Four study objectives were not achieved. The two objectives to test the validity of 
the framework in explaining the variance in the number of cancer-related ED visits and 
cancer-related hospitalizations were not achieved because very few patients reported 
incidents of ED visits (3.4%, N=5) or hospitalizations (1.4%, N=2) resulting from their 
breast cancer in the last 30 days. In addition, the two objectives to predict these outcomes 
were not achieved. Table 4.15 contains details of the study objectives/hypotheses that were 
tested and corresponding results. 
 
Table 4.15 Summary of Study Objectives and Hypotheses Test Results 
Objectives/Hypotheses Statistical Test Results 
Objective 1: To describe health literacy, 
patient activation, clinical (stage of breast 
cancer at diagnosis, time since diagnosis, 
type of breast cancer treatment received, 
comorbidities) and demographic (age, 
gender, educational level, ethnicity, 
household income, insurance status, 
marital status) characteristics of a breast 
cancer patient sample.  
Mean, 
Standard 
deviation (SD), 
Frequency 
 Average age 57.1 ± 10.8 years  
 99% female  
 53% had at least a college 
degree  
 72% Caucasian  
 66% had an annual household 
income over $50,000 
 60% had private insurance  
 70% married or in a 
relationship  
 92% had adequate cancer 
health literacy 
 79% had adequate general 
health literacy 
 68% in the higher levels (level 
3 or 4) of activation 
 Equal distribution of patients 
from stage 1 to stage 4 
 78% had been diagnosed for 
the first time within the last 5 
years  
 79% had at least 1 comorbidity 
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Table 4.15 Summary of Study Objectives and Hypotheses Test Results Contd. 
 
Objective 2: To examine the relationships 
between health literacy and clinical and 
demographic characteristics in a sample of 
breast cancer patients. 
T test 
Fisher test 
Cancer Health Literacy 
 Significant relationships with 
household income and 
educational level 
General Health Literacy 
 Significant relationships with 
age, educational level, and 
insurance 
Objective 3:  To examine the relationships 
between patient activation and clinical and 
demographic characteristics in a sample of 
breast cancer patients. 
Correlation 
ANOVA 
 Significant relationship with 
ethnicity 
 
Objective 4:  To assess the relationship 
between cancer health literacy and patient 
activation in a sample of breast cancer 
patients. 
H1: Breast cancer patients who have 
adequate cancer health literacy will have 
higher patient activation compared to 
those with limited cancer health literacy 
T test 
 Hypothesis H1 not supported 
 
Objective 5: To examine the relationship 
between cancer health literacy and patient-
provider communication in a sample of 
breast cancer patients. 
H2: Breast cancer patients who have 
adequate cancer health literacy will have 
easier patient-provider communication 
and understanding of information 
provided compared to those that have 
limited cancer health literacy. 
T test  Hypothesis H2 not supported 
 
Objective 6: To examine the relationship 
between cancer health literacy and general 
health literacy in a sample of breast cancer 
patients. 
H3: There will be a significant positive 
relationship between cancer health 
literacy and general health literacy in the 
sample of breast cancer patients. 
Chi-square test Hypothesis H3 supported 
 109 
Table 4.15 Summary of Study Objectives and Hypotheses Test Results Contd. 
 
Objective 7:  To determine the overall 
predictive validity of the health literacy 
skills (HLS) framework in explaining 
health outcomes (cancer health-related 
quality of life, cancer-related emergency 
department visits, and cancer-related 
hospitalizations), using cancer health 
literacy and patient activation, controlling 
for clinical/demographic characteristics. 
H4: Cancer health literacy and patient 
activation will explain a significant 
amount of variance in cancer health-
related quality of life controlling for 
clinical and demographic characteristics. 
H5: Cancer health literacy and patient 
activation will explain a significant 
amount of variance in cancer-related 
emergency department visits controlling 
for clinical and demographic 
characteristics. 
H6: Cancer health literacy and patient 
activation will explain a significant 
amount of variance in cancer-related 
hospitalizations controlling for clinical 
and demographic characteristics. 
Multiple linear 
regression: 
R2; F test 
Hypothesis H4 supported 
Hypothesis H5 not tested 
Hypothesis H6 not tested 
 
Objective 8:  To predict health-related 
quality of life in breast cancer patients 
using cancer health literacy and patient 
activation controlling for clinical and 
demographic characteristics.    
H7: Cancer health literacy and patient 
activation will be significant positive 
predictors of cancer health-related 
quality of life controlling for clinical 
and demographic variables. 
Multiple linear 
regression: 
R2; F test 
Hypothesis H7 partially 
supported 
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Table 4.15 Summary of Study Objectives and Hypotheses Test Results Contd. 
 
Objective 9: To predict cancer-related 
emergency department visits in breast 
cancer patients using cancer health literacy 
and patient activation controlling for 
clinical and demographic characteristics.  
H8: Cancer health literacy and patient 
activation will be significant negative 
predictors of cancer-related emergency 
department visits controlling for clinical 
and demographic characteristics. 
Multiple linear 
regression: 
R2; F test 
Hypothesis H8 not tested 
 
Objective 10: To predict cancer-related 
hospitalizations in breast cancer patients 
using cancer health literacy and patient 
activation controlling for clinical and 
demographic characteristics.  
H9: Cancer health literacy and patient 
activation will be significant negative 
predictors of cancer-related 
hospitalizations controlling for clinical and 
demographic characteristics. 
Multiple linear 
regression: 
R2; F test 
Hypothesis H9 not tested 
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Significant 
Not significant 
Not tested   
*Significant relationship with cancer health literacy 
**Significant relationship with patient activation  
Figure 4.2 Health Literacy Skills Framework Showing Significant Relationships 
 
 
 
 
 
 
 
Cancer health-related 
quality of life  
Intermediate factor Health outcomes 
Cancer health 
literacy  Patient activation 
Cancer-related 
hospitalizations 
Cancer-related 
emergency 
department visits 
Control variables – educational level*, age, gender, ethnicity**, health insurance, comorbidities, 
income* 
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Chapter 5: Discussion and Conclusion 
This study assessed health literacy and patient activation in HER-2 positive breast 
cancer patients and also examined the ability of these constructs to explain and predict 
health outcomes using the Health Literacy Skills (HLS) framework. This study also 
explored the relationships of health literacy and patient activation with 
clinical/demographic patient characteristics. In addition, the relationship of general health 
literacy and patient activation with cancer health literacy was examined. Lastly, the 
relationship between cancer health literacy and patient-provider communication was 
assessed. 
This chapter consists of five sections. The first section contains a discussion of 
study findings and possible explanations of the findings. The second section explores the 
implications of study findings. The third section discusses the study limitations, and the 
last two sections consist of suggestions for future research and the conclusion.  
 
5.1 Discussion of Study Findings 
5.1.1 Participation Rate and Study Sample Characteristics 
The participation rate of this study was high as almost 90 percent (N=146) of 
patients who were approached by clinic staff and offered participation in the study, gave 
their consent to participate and completed the survey. This high participation rate could 
have resulted because the approached patients were interested in contributing to the 
potential improvement of breast cancer care experience and also because they were asked 
to complete the survey during their office visit. 
The average age of study participants was 57.1±10.8 years which coincides with 
the average age at breast cancer diagnosis of 61 years in United States women. About 19 
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percent of breast cancer cases occur among women younger than 50 years, while 44 percent 
occur in women older than 65 years.2 Since breast cancer affects many more women than 
men,56 it was not surprising that 99 percent of study participants were female. Only one 
male participated in the study. The study participants were predominantly Caucasian 
(71.7%), married or in a relationship (69.5%), had a high formal education level (52.8%), 
had private insurance (59.7%), and had an annual household income over $50,000 (66.2%). 
These characteristics suggest that this sample of breast cancer patients were 
socioeconomically advantaged.  
Clinically, the study participants were almost equally distributed from cancer stage 
1 to stage 4 with about half being newly diagnosed (within the last year) breast cancer 
patients (N=73). Also, a majority of the patients (73.3%) had at least one comorbidity. This 
was not surprising, given the average age of study participants, as the prevalence of 
comorbidity increases with age. A study published by Fu et al. in 2015 which evaluated 
the association of comorbidities with quality of life in breast cancer survivors showed that 
73.8 percent of the 134 breast cancer survivors had at least one comorbidity.150  
Even though the majority of breast cancer patients in this study were Caucasian, 
the United States breast cancer population is more varied, with Blacks being almost as 
much as Caucasians, and Hispanics being slightly less than Asian/Pacific Islanders. 
However, there is a disproportionate death rate resulting from breast cancer among Black 
breast cancer patients with about eight more deaths per 100,000 occurring in black women 
than in white women. Black breast cancer patients also have a five-year relative survival 
rate that is 10 percent lower than that of white women.151 These disparities have been 
attributed to socioeconomic disadvantages as well as differences in the clinical 
manifestation of breast cancer in this sub-population. Black breast cancer patients are more 
likely to be diagnosed at a later stage and have an aggressive type of breast cancer (triple 
 114 
negative). They are also more likely to have insurance-related barriers to accessing health 
care.152-154 In Hispanics, the lower rate of breast cancer incidence and mortality compared 
to non-Hispanic Whites might not necessarily be a true picture of reality. These lower rates 
could partially be attributed to lower rates of mammography utilization and delayed follow-
up of abnormal screening results in this sub-population.155,156 It is therefore important for 
healthcare providers to be mindful of the barriers that might affect ethnic minorities in 
having optimal breast cancer outcomes and be proactive in helping such patients overcome 
avoidable barriers. 
 
5.1.2 Primary Study Variables 
Health Literacy in Breast Cancer Patients 
The majority of participants had adequate cancer health literacy (92%, N=134) and 
adequate general health literacy (79%, N= 114) based on their CHLT-6 and NVS scores, 
respectively. Even though these two constructs had a significant relationship with each 
other, the higher percentage of patients with adequate cancer health literacy confirms that 
the cancer health literacy tool has more specificity in assessing the health literacy level of 
cancer patients. There were also significant relationships between cancer health literacy 
and household income and educational level. Patients with higher incomes and formal 
education showed adequate cancer health literacy compared to their counterparts. General 
health literacy was also related to higher formal education, younger age and having private 
insurance.  
These sociodemographic differences in health literacy (cancer-specific and general) 
corroborate extant literature in both cancer and non-cancer populations which support a 
positive relationship between health literacy and socioeconomic status. For example, 
Dumenci et al. described the development of the 30-item and 6-item cancer health literacy 
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instruments designed to measure cancer health literacy along a continuum and identify 
patients with limited cancer health literacy, respectively. The study population consisted 
of a wide variety of cancer patients including breast, colon, gastrointestinal, skin, and 
hematologic cancers. Results showed that compared to individuals with adequate cancer 
health literacy (CHL), those with limited CHL were likely to be Black, have a low 
educational level, have a low income, not be privately insured, and most likely did not 
engage in health decisions.18  
In another study, Rikard et al. found that health literacy had a significantly negative 
association with age, but a significantly positive association with household income and 
education in a population of 14,592 United States adults who took the 2003 National 
Assessment of Adult Literacy (NAAL). Health literacy level increased by a quarter of a 
point for every additional thousand dollars in median household income, while it increased 
by nearly four points for each additional level of educational attainment.157 
 
Patient Activation in Breast Cancer Patients 
Patient activation, a secondary independent variable, was relatively high 
(65.9±15.7), resulting in the majority of breast cancer patients (68%, N= 99) being in the 
higher activation levels (PAM level 3 or 4). Patient activation was significantly higher in 
Caucasians (68.9±16.0) compared to Blacks (54.5±6.9) and Hispanics (58.3±10.7). 
This result is similar to findings of other studies which showed that ethnic 
minorities including Blacks and Hispanics are more likely to have lower patient activation 
than Caucasians. Hibbard et al.’s 2008 study that explored the role that patient activation 
may have in racial and ethnic health disparities revealed that mean patient activation score 
for Caucasians was four points higher than that of African Americans in both national and 
Medicaid samples.158 Using the 2007 Health Tracking Household Survey, Cunningham et 
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al. found similar patterns whereby compared to Caucasians and African Americans, 
Hispanics had much lower levels of patient activation with only 24.8 percent of Hispanics 
at the highest level of patient activation (PAM level 4), compared to 39.5 percent of Blacks 
and 45.3 percent of Whites.35,36 
Patients with low activation levels are more likely to have unmet medical needs and 
delay medical care, compared with more activated patients.29 In addition, they are less 
likely to be aware of treatment guidelines for their condition or seek out health 
information.30 These behavior patterns foster avoidable misuse of scarce healthcare 
resources including a greater number of visits to the emergency department and 
hospitalizations.159,160 Low patient activation in breast cancer patients could result in 
patients being less capable of accessing available medical resources for managing breast 
cancer. Such patients might also find it more difficult to coordinate care among different 
providers, and not readily identify symptoms that signify worsening of health or a 
relapse/recurrence. 
Consequently, it is important for health care providers to understand that a patient’s 
ability to manage their health and healthcare are inextricably tied to their social and 
economic circumstances. These social determinants are related to patient activation and 
should inform interactions to meet patients at their level. Adopting a one-size-fits-all 
approach for encouraging breast cancer patients to proactively manage their care will most 
likely miss the mark for a significant number of breast cancer patients. 
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Cancer Health Literacy and Patient Activation 
Health literacy is related to the ability to use information in making health-relevant 
decisions while patient activation is associated with chronic disease self-management.47  
Studies that have investigated the relationship between health literacy and patient 
activation show conflicting results – some have found a weak positive correlation while 
others have found no association between the two constructs. A study by Smith et al. 
showed a weak, positive correlation between general health literacy and patient activation 
(r = 0.11, p = 0.005) among an older (aged 55 to 74 years) sample of patients who received 
care from a primary care clinic or one of three federally qualified health centers in Chicago, 
Illinois. In their study, 31.3 percent of study participants had limited literacy skills 
according to the Test of Functional Health Literacy in Adults (TOFHLA), while 83.5 
percent were in the highest category of patient activation (PAM level 4).44 Another study 
by Dunlay et al. also showed a positive association between health literacy and patient 
activation in a sample of 302 elderly patients who were hospitalized with acute 
decompensated heart failure at Mayo Clinic hospitals in Rochester, Minnesota. Health 
literacy was assessed using a 3-item Health Literacy Screener, and 28 percent of patients 
had poor health literacy according to this measure. These patients with poor health literacy 
had low patient activation as well.161 
Conversely, Couture et al. found no association between general health literacy and 
patient activation (biserial correlation – rb: 0.075, p = 0.07) among patients with chronic 
diseases including diabetes, cardiovascular disease, respiratory disease, musculoskeletal 
disease, and chronic pain. Most study participants had considerable illness burden, with an 
average of six chronic diseases. 67.5 percent of patients had limited health literacy as 
measured by the Newest Vital Sign (NVS), while 65.1 were in the higher levels of 
activation (PAM levels 3 and 4).162 
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The relationship between cancer health literacy and patient activation was not 
significant in this population of breast cancer patients, even though a positive and 
significant relationship was expected. This might have been because a majority of study 
participants had adequate cancer health literacy as measured by the CHLT-6. The limited 
variability in cancer health literacy level of study participants could have contributed to the 
non-significance of study results.  
 
Cancer Health Literacy and Patient-Provider Communication 
The majority of patients found it easy both to communicate their breast cancer 
concerns to their healthcare provider and to understand information given by healthcare 
providers about breast cancer and its management. However, there was no significant 
difference in the ease of communicating breast cancer concerns to a healthcare provider 
between patients with limited cancer health literacy (4.5±0.7) and patients with adequate 
cancer health literacy (4.6±0.7). Also, there was no significant difference in the ease of 
understanding information given by healthcare providers about breast cancer and its 
management between patients with limited cancer health literacy (3.7±1.2) and patients 
with adequate cancer health literacy (4.3±0.8).  
The relationship between health literacy and patient-provider communication might 
not have been significant due to a ceiling effect as most patients found it easy to 
communicate with their providers and understand information. However, a cancer patient’s 
health literacy level plays an important role in his or her ability to discuss disease, treatment 
options, and prognosis with a healthcare provider in a meaningful way. In a study by 
Williams et al. that aimed to explore and identify communication and decision making 
between health care providers and African American cancer patients/caregivers, 
participants consistently described the importance of communication with their physicians 
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to overall quality of life. They also stressed the importance of the physician connecting 
with patients (and their families) on a personal level as this would foster conversations 
where the information provided is appropriate for patients’ health literacy level as well as 
their stage of acceptance/denial of the disease and care options.163  
The National Cancer Institute and the Institutes of Medicine have emphasized that 
high quality cancer care involves patient-centered communication with healthcare 
providers.164-166 When healthcare providers effectively communicate with cancer patients 
and their families, there are improvements in patients’ quality of life, satisfaction with care, 
and health outcomes.167 It is thus important for healthcare providers to ensure that 
communication with cancer patients encompasses follow-up care, side effects of cancer 
treatment, emotional/social cancer-related needs, and lifestyle recommendations.168,169 
Since it might be overwhelming to effectively discuss issues in these four areas in one visit, 
interactions could be designed to provide information relevant to individual patient’s 
literacy level and position in the cancer care journey. Also, keeping tabs on areas that have 
been discussed in patient records could enable healthcare providers to easily identify areas 
that have not been covered and subsequently ensure that they are addressed with the patient 
in future clinic visits. Healthcare providers could further optimize interactions with patients 
by using plain language as much as possible, using pictures to support spoken directions, 
presenting recommendations as action plans, and soliciting patient feedback to ensure 
comprehension.21,170,171 
 
5.1.3 Evaluation of Health Literacy Skills (HLS) Framework 
The HLS framework describes how health literacy affects health outcomes such as 
health status, emergency care, and hospitalization through intermediate factors including 
disease and self-care knowledge.123 The patient activation measure was used to assess 
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disease and self-care knowledge, while the CHLT-6 measured cancer health literacy. The 
only health outcome measure evaluated in this study was health status (cancer health 
related quality of life) because there were too few reported incidents of cancer-related ED 
visits and hospitalizations.  
Study findings supported the overall predictive validity of the HLS framework in 
explaining health-related quality of life (F=10.31; df=4, 139; p<0.0001), in that twenty 
three percent of the variation in cancer health-related quality of life could be explained by 
cancer health literacy, patient activation, educational level, and number of treatment types 
received. Higher patient activation was related to higher health-related quality of life even 
after accounting for cancer health literacy, education and number of treatment types 
received.  A 1-point increase in patient activation score was associated with a 0.4-point 
increase in overall quality of life score, holding other predictors in the model constant. 
Cancer health literacy was not predictive. 
Our findings are supported by other studies that have investigated the relationship 
between patient activation and quality of life. Magnezi et al. reported a significant positive 
correlation between patient activation and the total quality of life scores as measured by 
Short Form-12 Health Survey (SF-12), as well as the physical and mental health subscale 
scores in primary care patients. Participants generally had a high quality of life (32.1±8.3, 
range of 12 to 44).172 
Another study by Blakemore et al., showed that patient activation was significantly 
lower in individuals with poor health literacy and higher in those with good quality of life 
in a large cohort of older adults (65 years and older). The Single Item Literacy Screener 
(SILS) was used to measure health literacy and the EuroQol EQ-5D-5L health utility index 
was used to measure health related quality of life.173 These results support the association 
between quality of life and patient activation. The non-significance of the relationship 
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between health literacy and patient activation in this study may be due to the dichotomous 
nature of the cancer health literacy instrument used. 
 
5.2 Summary and Implications 
Study participants were found to have high levels of health literacy and patient 
activation in general. This was not surprising as most of the breast cancer patients were 
socioeconomically advantaged, and socioeconomic status is positively associated with 
these constructs.90,133 The cancer health literacy instrument (CHLT-6) also showed more 
specificity in detecting breast cancer patients’ health literacy level compared to the general 
health literacy instrument (NVS). With regards to patient-provider interaction, study 
participants mostly found it easy to communicate their breast cancer concerns to their 
healthcare provider and also understand information given by healthcare providers about 
breast cancer and its management.  
Study participants generally reported a high health-related quality of life. However, 
only a few patients reported cancer-related ED visits and hospitalizations, so the 
relationship of resource utilization with health literacy and patient activation could not be 
assessed. Finally, the HLS framework was significant, with cancer health literacy, patient 
activation, educational level, and number of treatment types received explaining over a 
fifth of the variance in patients’ health-related quality of life. 
Breast cancer is no longer viewed as a terminal disease but is now considered to be 
a chronic condition due to improvements in detection, diagnosis, and treatment.174 
Increasingly, patients with chronic diseases, including breast cancer, are being expected to 
participate in managing their care. This study’s findings further validate extant literature 
that patients’ involvement in self-managing their health and healthcare (patient activation) 
is positively associated with quality of life.133,172,173 To our knowledge, this is the first study 
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to specifically explore this relationship in breast cancer patients. In addition to improved 
quality of life, higher patient activation levels have been associated with better health 
outcomes and resource utilization in other chronic conditions including diabetes, heart 
failure, and asthma.38,160 It is not far-fetched to assume that such associations would also 
apply in breast cancer patients.  
Highly activated cancer patients tend to be better informed and more proactive 
about managing their condition.37 They are also more likely to understand their diagnosis, 
efficiently manage side effects, feel sufficiently informed about their treatment plan, and 
have their values reflected in their treatment plans. Furthermore, poorly activated cancer 
patients tend to be less satisfied with their care.122 Therefore, cancer care providers should 
consider assessing patient activation at the beginning of cancer care and subsequently 
encouraging their breast cancer patients to participate in managing their care as a quality 
metric of care. The patient-provider discourse about self-management in the oncology 
space can also be designed to accommodate all patients irrespective of their health literacy 
level, and could encompass issues relevant to the cancer patient including support of patient 
autonomy, guidance to navigate the healthcare system, and access to resources.166 
 
5.3 Study Limitations 
This study was adequately powered, and patients were recruited from multiple 
clinics in Texas. However, there are some study limitations that should be considered while 
interpreting study findings. These are discussed in detail below.  
First, all the data used in the study were self-reported. There was no objective 
validation of participants’ responses which could have been subject to recall bias or a desire 
to please. Another limitation to this study is selection bias as a result of convenience 
sampling. Patients who participated in this study volunteered to do so. It is possible that 
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patients with high health literacy and high patient activation levels were more likely to be 
interested in being part of a study that could potentially improve breast cancer patients’ 
care experience. Also, clinic staff might have been more likely to offer such patients 
participation in the study. Next, given the descriptive and cross-sectional nature of this 
study, causality cannot be inferred. Even though the study sample was from multiple clinics 
within a Texas-based oncology group, the findings might still not be representative of the 
breast cancer population in Texas or nationally, particularly because most of the study 
participants were socioeconomically advantaged. In addition, the participating oncology 
clinics implement the Oncology Care Model (OCM) and other value-based care models 
designed to improve patient care and the cancer treatment experience. Consequently, the 
study results can only be generalizable to breast cancer patients similar to those that 
participated in the study and receive care from similar types of practices. In addition, the 
recall period (30 days) for the items measuring the number of cancer-related ED visits and 
hospitalizations in this sample of breast cancer patients might have been too short to 
adequately capture these outcome measures. Finally, the patient activation score of study 
participants pertained to their knowledge/ability to self-manage their breast cancer care and 
may not necessarily indicate how they would manage other comorbidities/chronic 
conditions. 
 
5.4 Suggestions for Future Research 
Future research could further validate the HLS framework by exploring the 
relationship of health outcomes such as the number of cancer-related ED visits and 
hospitalizations with health literacy and patient activation using a longer recall period. This 
might yield actual results even though the chances of recall bias would be higher. 
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Alternatively, the number of ED visits and hospitalizations could be objectively obtained 
from electronic medical records or a healthcare database, if available. 
In addition, other studies that explore cancer health literacy might yield significant 
findings with a non-dichotomous cancer health literacy instrument like the CHLT-30. Even 
though the CHLT-6 adequately distinguishes individuals with limited health literacy from 
those with adequate health literacy, it does not detect degrees of limitedness or adequacy 
of cancer health literacy. Therefore, it might be more useful in future studies to use the 
longer 30-item cancer health literacy tool, or a similar instrument, which measures cancer 
health literacy along a continuum. 
 
 5.5 Conclusion 
This study lends support to the utility of the HLS framework in predicting health-
related quality of life in HER-2 positive breast cancer patients.  Findings show that both 
modifiable factors such as patient activation and number of treatment types as well as a 
non-modifiable factor (education) were significant and positive predictors of quality of life. 
In addition, Blacks and Hispanics were found to have significantly lower patient activation 
levels than Caucasians. Paying attention to these factors in interventions aimed to improve 
quality of life are recommended. Cancer health literacy was not predictive, although the 
high levels and homogeneity of cancer health literacy among study participants could have 
impacted the results. Further assessments of health literacy and patient activation with 
quality of life as well as other health outcomes in larger and more diverse populations of 
breast cancer patients are warranted.  
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Appendices 
Appendix 1: Survey Instrument 
 
Patient study number: _________________ 
 
Section 1:  We would like to better understand your needs for information about breast cancer. 
This set of questions involves basic cancer health information. Please check the option that best 
corresponds to your answer for each question. 
 
1.      The normal range for hemoglobin for a male is 13.3 to 17.2g/dl. Joe’s hemoglobin is 9.7g/dl. Is Joe 
within the normal range?  
□ Yes  
□ No 
 
2.      A biopsy of a tumor is done to ________ 
□ Remove it 
□ Diagnose it  
□ Treat it  
 
3.      If a patient has stage 1 cancer, it means the cancer is ________ 
□ Localized  
□ In nearby organs 
□ In distant sites  
 
4.      The role of a physical therapist is to talk to a patient about emotional needs.  
□ True  
□ False  
 
5.      A tumor is considered ‘‘inoperable’’ when it cannot be treated with ________ 
□ Radiation therapy  
□ Surgery  
□ Chemotherapy  
 
6.    Sally will get radiation therapy once a day, Monday through Friday. If Sally has therapy for 4         
weeks, how many times will she get radiation therapy?  
□ 5  
□ 15  
□ 20 
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Section 2: We would also like to understand your ability to interpret general health information. 
This set of questions require you to find and interpret information presented on a nutrition label 
for a pint of ice cream. Please fill in your response for each question. 
 
  
Nutrition Facts  
Serving Size ½ cup 
Servings per 
container 
4 
Amount per serving 
Calories        250 
 
  Fat Cal       120 
 %DV 
Total Fat 13g 20% 
      Sat Fat 9g 40% 
Cholesterol 28mg 12% 
Sodium 55mg 2% 
Total Carbohydrate 30g 12% 
      Dietary Fiber 2g  
      Sugars 23g  
Protein 4g 8% 
*Percentage Daily Values (DV) are based 
on a 2,000 calorie diet. Your daily values 
may be higher or lower depending on 
your calorie needs 
Ingredients: Cream, Skim Milk, Liquid 
Sugar, Water, Egg Yolks, Brown Sugar, 
Milkfat, Peanut Oil, Sugar, Butter, Salt, 
Carrageenan, Vanilla Extract. 
 
  
7.       If you eat the entire container, how many   
calories will you eat?  _______________ 
 
8.       If you are allowed to eat 60g of 
carbohydrate as a snack. How much ice-
cream could you have? _______________ 
 
9.      Your doctor advises you to reduce the 
amount of saturated fat in your diet. You 
usually have 42g of saturated fat in your diet 
each day which includes 1 serving of ice 
cream. If you stopped eating ice cream, how 
many grams of saturated fat will you be 
consuming daily? _____________ 
 
10.    If you usually eat 2500 calories in a day, 
what percentage of your daily value of 
calories will you be eating if you eat one 
serving? _______________ 
 
Pretend that you are allergic to the following 
substances: Penicillin, peanuts, latex gloves, and 
bee stings 
 
11.    Is it safe for you to eat this ice cream? ____ 
 
12.    If no, why not? _______________________ 
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Section 3: This set of questions asks about your involvement in managing your breast cancer. 
Please check the option that best corresponds to your response for each question. 
 
 Disagree 
Strongly 
Disagree Agree Agree 
Strongly 
N/A 
13.    When all is said and done, I am the person 
who is responsible for managing my breast 
cancer. 
 
□ □ □ □ □ 
14.    Taking an active role in my own breast 
cancer care is the most important factor in 
determining my health and ability to 
function. 
 
□ □ □ □ □ 
15.    I am confident that I can take actions that 
will help prevent or minimize some 
symptoms or problems associated with my 
breast cancer. 
 
□ □ □ □ □ 
16.    I know what each of my prescribed breast 
cancer medications does. 
 
□ □ □ □ □ 
17.    I am confident that I can tell when I need to 
go get medical care and when I can handle a 
breast cancer-related problem myself. 
 
□ □ □ □ □ 
18.    I am confident I can tell a doctor breast 
cancer-related concerns I have even when he 
or she does not ask. 
 
□ □ □ □ □ 
19.    I am confident that I can follow through on 
breast cancer medical treatments I need to do 
at home. 
 
□ □ □ □ □ 
20.    I understand the nature and causes of my 
breast cancer. 
 
□ □ □ □ □ 
21.    I know the different medical treatment 
options available for my breast cancer. 
 
□ □ □ □ □ 
22.    I have been able to maintain the lifestyle 
changes for my health that I have made. 
 
□ □ □ □ □ 
23.    I know how to prevent further problems with 
my health. □ □ □ □ □ 
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 Disagree 
Strongly 
Disagree Agree Agree 
Strongly 
N/A 
24.    I am confident I can figure out solutions 
when new situations or problems arise with 
my health. 
 
□ □ □ □ □ 
25.    I am confident I can maintain lifestyle 
changes, like diet and exercise, even during 
times of stress. 
  
□ □ □ □ □ 
 
Section 4: Below is a list of statements that other people with breast cancer have said are 
important. Please select one number per line to indicate your response as it applies to the past 7 
days. 
   
Not at 
all 
A little 
bit 
Somewhat Quite a 
bit 
Very 
much 
Physical well-being 
 
26.    I have a lack of energy. 
 
0 1 2 3 4 
27.    I have nausea. 
 
0 1 2 3 4 
28.    Because of my breast cancer, I have trouble 
meeting the needs of my family. 
  
0 1 2 3 4 
29.    I have pain. 
  
0 1 2 3 4 
30.    I am bothered by side effects of breast cancer 
treatment. 
  
0 1 2 3 4 
31.    I feel ill. 
  
0 1 2 3 4 
32.    I am forced to spend time in bed. 
 
0 1 2 3 4 
Social/family well-being 
 
33.    I feel close to my friends. 
  
0 1 2 3 4 
34.    I get emotional support from my family. 
  
0 1 2 3 4 
35.    I get support from my friends. 
  
0 1 2 3 4 
36.    My family has accepted my breast cancer. 
 
0 1 2 3 4 
37.    I am satisfied with family communication 
about my breast cancer. 
 
0 1 2 3 4 
38.    I feel close to my partner (or the person who 
is my main support). 
0 1 2 3 4 
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 Not at 
all 
A little 
bit 
Somewhat Quite a 
bit 
Very 
much 
Regardless of your current level of sexual activity, 
please answer the following question. If you prefer 
not to answer it, please mark this box           and 
go to the next question. 
39.    I am satisfied with my sex life. 
 
0 
 
1 
 
2 
 
3 
 
4 
 
Emotional well-being 
 
40.    I feel sad. 
 
0 1 2 3 4 
41.    I am satisfied with how I am coping with my 
breast cancer. 
 
0 1 2 3 4 
42.    I am losing hope in the fight against my 
breast cancer. 
 
0 1 2 3 4 
43.    I feel nervous. 
 
0 1 2 3 4 
44.    I worry about dying. 
 
0 1 2 3 4 
45.    I worry that my breast cancer will get worse. 
 
0 1 2 3 4 
Functional well-being 
 
46.    I am able to work (include work at home).  0 1 2 3 4 
47.    My work (include work at home) is 
fulfilling. 
 
0 1 2 3 4 
48.    I am able to enjoy life. 
 
0 1 2 3 4 
49.    I have accepted my breast cancer. 0 1 2 3 4 
50.    I am sleeping well. 
 
0 1 2 3 4 
51.    I am enjoying the things I usually do for fun. 
 
0 1 2 3 4 
52.    I am content with the quality of my life right 
now. 
 
0 1 2 3 4 
 
Section 5: The next 2 questions are about how often (if at all) severe breast cancer symptoms 
have resulted in you visiting the emergency department or being hospitalized. Please fill in the 
blank space for each question. 
 
53.    Within the last one month, how many emergency department visits have you had due to a breast 
cancer complication? _______________ (indicate the number of times) 
  
54.    Within the last one month, how many hospitalizations have you had due to a breast cancer 
complication? _______________ (indicate the number of times) 
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Section 6: The next 2 questions are about how you communicate with your health provider(s) 
about breast cancer. Select the option that best corresponds to your answer for each question. 
 
55.    How difficult is it for you to communicate your concerns about your breast cancer to your 
healthcare provider(s)? 
□ Extremely difficult 
□ Somewhat difficult 
□ Neither easy nor difficult 
□ Somewhat easy 
□ Extremely easy 
 
56.    How difficult is it for you to understand the information provided by your healthcare provider(s) 
about your breast cancer and its management? 
□ Extremely difficult 
□ Somewhat difficult 
□ Neither easy nor difficult 
□ Somewhat easy 
□ Extremely easy 
 
 
Section 7: Finally, we would like to learn a little about you and the present state of your breast 
cancer. Please fill in your response or select the option that best corresponds to your answer for 
each question.  
  
57.    What year were you born in?     _____ 
  
58.    Which option best describes your gender?       
□ Male         
□ Female         
□ Transgender         
□ Other  
 
59.    Which of the following best describes your race/ethnicity? 
□ African-American or non-Hispanic black  
□ American Indian or Alaska Native 
□ Asian-American or Pacific Islander 
□ Caucasian or non-Hispanic white 
□ Mexican-American or Hispanic 
□ Other (please specify) _____________ 
 
60.    What is your highest level of education? 
□ Less than High School 
□ High School Graduate or GED  
□ College graduate 
□ Postgraduate (e.g., MD, MS, PhD)    
□ Other (please specify) _____________ 
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61.    Which option best describes your annual household income? 
□ Less than $25,000 
□ $25,000 to $50,000 
□ > $50,000 to $75,000 
□ > $75,000 to $100,000 
□ >$100,000 
  
62.    Which option best describes the type of health insurance you currently have? 
□ No insurance/Self-pay                 
□ Private insurance (e.g. BlueCross/Blue Shield, Humana)  
□ Medicare          
□ Medicaid                                                                         
□ Not sure 
□ Other (please specify) _______________ 
 
63.    Which option best describes your marital status? 
□ Single, in a relationship                                         
□ Single, not in a relationship  
□ Married                 
□ Partner/Living together         
□ Divorced/Separated 
□ Widowed 
 
64.    At what stage was your breast cancer diagnosed? 
□ Stage 0                                                            □ Stage 3 
□ Stage 1                                                            □ Stage 4 
□ Stage 2                                                            □ Do not know 
 
65.    How long ago were you first diagnosed with breast cancer? 
□ 1 year or less                                                  □ More than 5 years but less than 10 years 
□ More than 1 year but less than 5 years     □ More than 10 years 
 
66.    Besides chemotherapy, what other type of breast cancer treatment have you received?  
Check all that apply. 
□ Radiation therapy 
□ Surgery (e.g. lumpectomy, mastectomy) 
□ Hormone therapy (e.g. Tamoxifen, Arimidex, Fareston, Femara, Falsodex, Aromasin)  
□ Other (please specify) _______________ 
 
67.    In addition to breast cancer, what other illnesses do you have? Check all that apply.  
 
□ Asthma                      □ Arthritis                     □ Diabetes        □ Hypertension        
□ High cholesterol        □ Heart disease             □ Anxiety         □ Depression 
□ Thyroid problems      □ Kidney problems      □ Other (please specify) _________ 
 
This is the end of the survey. Thank you for participating! 
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Appendix 2: Cover Letter 
 
 
COLLEGE OF PHARMACY 
THE UNIVERSITY OF TEXAS AT AUSTIN 
 
Health Outcomes and Pharmacy Practice Division • 1 University Station A1930 • Austin, TX 78712-0127 
Phone: (512) 471-6892 • FAX (512) 471-8762 
  
Dear Patient, 
 
You are invited to participate in a study titled "Relationship between Health 
Literacy, Patient Activation, and Health Outcomes in Breast Cancer Patients." The study 
is being conducted by Chisom Kanu, M.Pharm, for her dissertation project along with Carolyn 
Brown, PhD, College of Pharmacy of The University of Texas at Austin, and Dr. Lalan 
Wilfong Texas Oncology, Austin, Texas. Kindly read the information below carefully before 
deciding whether or not to take part. Completing the survey will be taken as evidence of your 
consent to participate in the study. 
The purpose of this research study is to assess your understanding of basic cancer 
information, your ability to manage your health, as well as how this understanding of cancer 
information and self-management abilities affect your health. You will be required to complete 
one survey during this clinic visit which should take no more than 10 minutes to complete. The 
study will include approximately 150 breast cancer patients.  
Your participation in the study will help facilitate the provision of appropriate 
information to breast cancer patients thereby increasing patient ability to be involved in self-
managing their health and having better outcomes.  
If you agree to participate: 
 
• The survey will take approximately 10 minutes of your time. 
 
Benefits/Risks/Confidentiality of Data 
There are no direct benefits from participating in this study. However, the findings of 
this study could help to increase the effectiveness of interventions to improve breast cancer 
patients’ involvement in managing their health. Also, the risk of participating in this study is 
considered minimal by the University of Texas at Austin Institutional Review Board. Your 
privacy and confidentiality will be protected by having clinic staff assign unique numbers to 
each study participant. Consequently, no individual response will be linked back to you. In 
addition, all completed surveys will be permanently deleted upon completion of the study and 
acceptance of manuscript(s).  
If it becomes necessary for the Institutional Review Board to review the study records, 
information that can be linked to you will be protected to the extent permitted by law. Your 
research records will not be released without your consent unless required by law or a court 
order. 
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Participation or Withdrawal 
Your participation in this study is voluntary and free of charge. You may decline to 
answer any question and you have the right to withdraw from participation at any time. 
Withdrawal will not affect your medical care, or your relationship with The University of Texas 
at Austin in any way.  If you do not want to participate, simply stop answering the survey 
questions.  You will be given the survey to complete by clinic staff at this clinic appointment. 
 
 
Contact information 
Prior, during, or after your participation in this study, you can contact Chisom Kanu at 
469-353-0844 or send an email to ckanu@utexas.edu if you encounter any problems or have 
any questions regarding the study. 
 
Questions about your rights as a research participant 
If you have questions about your rights or are dissatisfied at any time with any part of 
this study, you can contact, anonymously if you wish, the University of Texas at Austin 
Institutional Review Board by phone at (512) 471-8871 or email at orsc@uts.cc.utexas.edu.  
 
Thank you for your participation. 
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Appendix 3: Study Site Letter of Support 
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Appendix 4: Informed Consent Tracking Log 
 
 
 
 
STUDY TITLE: The Relationship between Health Literacy, Patient Activation, and Health 
Outcomes in Breast Cancer Patients 
PROTOCOL NO.: T0-1821 TEXAS ONCOLOGY CO-
INVESTIGATOR:  
Lalan S. Wilfong, MD 
SITE NAME: 
Date Patient Study ID Number Informed Consent Given?  Y/N 
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Appendix 5: Survey Evaluation Form 
 
Please evaluate the survey you just completed based on your experience with breast 
cancer and the care process. Kindly respond to the following questions as best as you 
can. Check Yes or No and add comments as appropriate. 
 
Readability of questions 
 
 Yes No 
Were all the questions clear?   
Were all the questions easy to understand?   
If you answered no, please specify which question(s) was problematic: 
 
Relevance of questions  
 
 Yes No 
Were all the questions relevant to the research 
topic? 
  
Were there any missing issues of importance?   
Please provide more details below: 
 
 
Format of survey 
 
 Yes No 
Was the survey layout user friendly?   
Did you find it hard to follow?   
Kindly state any suggestions for improvement below: 
Time to complete the survey  
 
 Yes No 
Did the survey take more than 10 minutes to 
complete? 
  
If you answered yes, please specify how long it took you to complete (in minutes): 
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